What Toxicologists and Risk Assessors Think About Hormesis: Results of a Knowledge and Opinion Survey by Jones, Amy C.
University of Massachusetts Amherst
ScholarWorks@UMass Amherst
Open Access Dissertations
2-2010
What Toxicologists and Risk Assessors Think
About Hormesis: Results of a Knowledge and
Opinion Survey
Amy C. Jones
University of Massachusetts Amherst, amy_jones@comcast.net
Follow this and additional works at: https://scholarworks.umass.edu/open_access_dissertations
Part of the Public Health Commons
This Open Access Dissertation is brought to you for free and open access by ScholarWorks@UMass Amherst. It has been accepted for inclusion in
Open Access Dissertations by an authorized administrator of ScholarWorks@UMass Amherst. For more information, please contact
scholarworks@library.umass.edu.
Recommended Citation
Jones, Amy C., "What Toxicologists and Risk Assessors Think About Hormesis: Results of a Knowledge and Opinion Survey" (2010).
Open Access Dissertations. 154.
https://scholarworks.umass.edu/open_access_dissertations/154
 
 
 
 
 
 
 
 
 
WHAT TOXICOLOGISTS AND RISK ASSESSORS THINK ABOUT 
HORMESIS: RESULTS OF A KNOWLEDGE AND OPINION SURVEY 
 
 
 
 
 
 
 
 
A Dissertation Presented 
 
 
by 
 
AMY C. JONES 
 
 
 
 
 
 
 
 
Submitted to the Graduate School of the 
University of Massachusetts Amherst in partial fulfillment 
of the requirements for the degree of 
 
DOCTOR OF PHILOSOPHY 
 
February 2010 
School of Public Health and Health Sciences 
Environmental Health Sciences 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by Amy C. Jones 2010 
 
All Rights Reserved 
 
 
 
WHAT TOXICOLOGISTS AND RISK ASSESSORS THINK ABOUT 
HORMESIS: RESULTS OF A KNOWLEDGE AND OPINION SURVEY 
 
 
 
 
 
 
 
A Dissertation Presented 
 
by 
 
AMY C. JONES 
 
 
 
 
 
 
Approved as to style and content by: 
 
______________________________________  
Edward J. Calabrese, Chair 
 
 
______________________________________  
Doug L. Anderton, Member 
 
 
______________________________________  
Edward J. Stanek, Member 
 
 
 
 
_______________________________ 
Edward J. Stanek, Department Head 
School of Public Health and Health 
Sciences 
DEDICATION 
 
To my sons Daniel and Nathan 
 ACKNOWLEDGMENTS 
 
I would like to acknowledge and thank everyone who helped and mentored me 
along the way.  I appreciate your supporting my desire to become a toxicologist after 
years of study and work as an engineer.  You all understood and supported my heartfelt 
goal to understand and assess human health risk caused by environmental and workplace 
exposures and to play a role as a protector of human health and the environment.    
I was fortunate to meet Dr. Edward Calabrese and that he accepted me into the 
Environmental Health Science Program.  I am privileged to have been his student.  I have 
learned so much from him and his dedicated and almost dogged inquiry into the 
phenomenon of the hormesis dose-response.   I thank him for his extreme patience in 
accommodating my demanding work schedule as I worked in a similar almost dogged 
fashion to complete the requirements for a doctoral degree in Environmental Health 
Science.  I would like to acknowledge the support, help and advice from my committee 
members Dr. Edward Stanek and Dr. Douglas Anderton.  I also thank Dr. George 
Hoffmann from Holy Cross University.  I appreciate all the hours of discussion and 
encouragement they provided in all phases of this study from survey instrument design, 
through data analysis and presentation of results. 
The high quality of the survey instrument that assured the internal validity of this 
study could not have been achieved without the input from the twenty-five leading 
toxicologists, risk assessors and health physics professionals who donated their time, 
energy and know-how to review the instrument multiple times and provide valuable 
comments and criticisms.  I thank you all. 
 v
 I owe a great debt of gratitude to Shawn Douglas Lamb and the Society of 
Toxicology.   The Society leadership and staff were enormously helpful and provided the 
very important comparative data without which this study could not have been completed 
and without which the external validity of this study could not have been achieved.  In 
that same vein, I also acknowledge and thank Dr. Robert Lichter of the Center for Health 
and Risk Communication at George Mason University.  His generous assistance in 
providing comparative demographic data from his concurrent survey of Society of 
Toxicology members gave me a wonderful opportunity to further evaluate the external 
validity of this study.  
Thank you to my close friends, dedicated supporters that provided nearly 
continuous encouragement to overcome the difficulties of working extremely demanding 
jobs while pursuing my goal of becoming a toxicologist.  To my more technically 
inclined friends, I appreciate the hours of discussion, exploration of ideas, and your 
reading and re-reading numerous versions of text.  To my not so technical friends, thank 
you for indulging me while I spent so much of your time talking about my passion for 
investigating this very interesting dose-response concept called hormesis.   
Finally, and most importantly I thank my loving, patient, and understanding 
family.  I thank my sister Grace Donnell for her valiant encouragement.  I thank my sons 
Daniel and Nathan for their never failing devotion; I dedicate this work to you both. 
 
 
 vi
  
 
ABSTRACT 
 
WHAT TOXICOLOGISTS AND RISK ASSESSORS THINK ABOUT 
HORMESIS: RESULTS OF A KNOWLEDGE AND OPINION SURVEY 
 
FEBRUARY 2010 
 
AMY C. JONES 
 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor Edward J. Calabrese 
 
Hormesis is a nonlinear dose-response characterized by biological responses at 
low doses that are opposite to those observed at higher doses.  Studies and review articles 
on hormesis are being published at an increasing rate by researchers from diverse 
disciplines and debate has emerged over the role hormesis in risk assessment.  As a 
result, a survey was conducted to assess toxicologists and risk assessors knowledge and 
attitudes about the hormesis dose response.  Study goals were to: 1) ascertain attitudes 
towards hormesis and other dose-response models, 2) identify whether acceptance or 
rejection of hormesis is based on knowledge of hormesis, predisposing values, or 
demographic characteristics, and 3) evaluate potential for response bias. The survey 
consisted of 44 questions pre-tested by 25 toxicologists and risk assessors.  The survey 
was distributed via email to the membership of the Society of Toxicology and the Society 
for Risk Analysis, 9,500 potential respondents. The overall response rate was 17% (n= 
1,463) with a completion rate over 87%.  Major findings were that 50% of respondents 
indicated sufficient data exist to support the view hormesis occurs across a wide range of 
species and endpoints, 59% indicated evaluating potential benefits due to hormesis 
 vii
 should be included in risk assessments, and 65% are in favor of modifying hazard 
assessment protocols to identify the presence of hormesis.  Respondent characteristics 
such as: years of experience, society membership, education, residence, employment 
(excluding government and pharmaceutical companies), and political, economic or social 
views had little influence on opinion. One of the largest positive influences was 
experience with hormesis based on actual research; 79% of subjects who reported 
observing hormesis commonly in their studies agreed hormesis is broadly generalizable. 
The influence of non-response bias was evaluated through several internal and external 
measures.  Despite a lower than hoped for response rate, but because of robust external 
validity measures, it is concluded that respondents’ opinions are likely a reasonable 
representation of the societies of which they are members. Because this is a baseline 
survey, a follow-up survey is in order.  Future survey design should separately evaluate 
the science of dose-response from the regulatory approach to risk assessment.    
 viii
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 CHAPTER 1 
INTRODUCTION 
1.1 Background and Purpose of Study 
Hormesis is a nonlinear dose-response phenomenon characterized by biological 
responses at low doses that are opposite to those observed at higher doses, leading to 
either a J-shaped or inverted U-shaped dose-response curve.  Evidence for hormesis has 
been published in the scientific literature from the late nineteenth century to the present 
(Calabrese and Baldwin, 1999; Henschler, 2006). Quantitative analysis of the hormesis 
dose-response curve began in earnest with the work of Calabrese and Baldwin (2001a). 
Their dose-response database provided the first analysis of the frequency in which the 
hormesis dose-response was reported in the scientific literature.  This work was followed 
by additional frequency analyses and a description of the quantitative features of the 
hormesis dose-response (Calabrese and Baldwin, 2001a,b, 2002a,b; Calabrese and Blain, 
2005).  Results consistent with a hormesis dose-response were shown to be widely 
observed in medicine, molecular biology, pharmacology, nutrition, aging/geriatrics, 
agriculture, microbiology, immunology, exercise physiology and toxicology.   
The data compiled by Calabrese and colleagues, coupled with numerous papers 
published by other researchers, indicate that hormesis is common, and highly 
generalizable across biological responses in numerous species, both plant and animal.  In 
December 2007, when the concept for the present study was first developed, an 
examination of the PubMed® database, which indexes over 5,000 journals, listed 398 
articles with the keyword hormesis that were published between 2000 through 2007.  
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 Most articles presented original dose-response research for which the author(s) selected 
hormesis as a keyword.  A summary of the types and content of a number of articles is 
included in the literature review in Chapter 2. 
Despite the widespread reporting of hormesis research and the inclusion of the 
hormesis dose-response phenomenon into leading toxicological textbooks, hormesis as a 
model has not been adopted by regulatory agencies or recommended by science policy 
experts for conducting hazard assessments.  In fact, the utility of hormesis for evaluating 
dose-responses from chemical hazard research has been and remains to this day intensely 
debated in the scientific literature of the field (Axelrod et al., 2004; Calabrese, 2005 a,b; 
Cook and Calabrese 2006a,b; Davis and Farland, 1998; Elliott, 2008a,b; Hoffmann, 2009; 
Holsapple and Wallace, 2008; Renn, 2008; Sandin, 2008; Thayer et al., 2006, 2005; 
Zapponi and Marcello, 2006).  
Outside of the journal-based debate but weighing-in on the topic is the United 
States Environmental Protection Agency (EPA).  In 2004, the agency implicitly rejected 
the use of the hormesis dose-response for conducting chemical hazard assessments and 
risk assessments.  In a staff paper evaluating its risk assessment process, EPA stated that 
“as the purpose of risk assessment is to identify risk (harm, adverse effect, etc.), effects 
that appear to be adaptive, non-adverse, or beneficial may not be mentioned” (EPA, 
2004). Furthermore, the EPA Guidelines for Carcinogen Risk Assessment (2005) state 
that “nonlinear approaches may only be used when data is sufficient to ascertain the 
mode of action and (emphasis added by EPA) the agent does not demonstrate mutagenic 
or other activity consistent with linearity at low doses”.  The guidelines indicate 
researchers must use the threshold model as the default model to derive a reference dose 
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 (RfD) or reference concentration (RfC) when the dose-response is non-linear, thereby 
excluding hormesis altogether. 
Because evidence of the hormesis dose-response effect is widely reported but still 
a matter of debate in the scientific literature, this study was undertaken and designed 
using the best available survey methodology to ascertain the prevailing attitudes, 
acceptance and reliance on hormesis as a scientifically valid concept among toxicologists 
and risk assessors.       
1.2 Study Goals 
  The goals of this first-ever study of the hormesis dose-response concept among 
toxicologists and risk assessment professionals were to: 1) ascertain attitudes towards 
hormesis and other dose-response models, 2) identify whether the level of acceptance or 
rejection of hormesis is based on knowledge of hormesis, predisposing values, or 
demographic characteristics, 3) evaluate potential for response bias, and 4) establish 
research priorities for hormesis.   
This study was designed to provide data that will aid in determining the status of 
hormesis as a dose-response concept accepted among toxicologists and to identify 
whether the level of acceptance or rejection of hormesis is knowledge-based or 
determined by predisposing values, demographic characteristics, and other factors.   
Furthermore, it is hoped that the results will enable researchers and regulators to 
better understand the direction of toxicological research, hazard assessment, risk 
assessment, public health policy development and risk communication as it is influenced 
by views on hormesis and other dose-response models.   
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 CHAPTER 2 
REVIEW OF THE LITERATURE 
2.1 Survey Methods 
The review of survey methods relies strongly on the works of Tanur (1992) and 
Fink (1995).  Development of sound surveys entails initially setting research objectives, 
followed by designing a research methodology to meet the research objectives, preparing 
a reliable and valid data collection instrument, administering the instrument, analyzing 
data, and reporting the results.  Detailed implementation of the guidance provided by 
Tanur and Fink is described in Chapter 3: Study Methods. The following is a short review 
of survey principles adopted for this survey research on the hormesis dose-response. 
2.1.1 Design 
The survey instrument must be designed to maximize the validity and reliability 
of the research.  The researcher must identify the target audience of the survey and 
develop relevant questions that are understandable to the target audience.  Therefore, the 
researcher must fully understand the issues and the respondents before development of 
the questions.   All ambiguous terms used in the survey’s questions must be clarified and 
clearly defined.  The survey researcher must assure to the best extent possible that the 
respondents have sufficient knowledge to answer the questions.  This is usually done by 
pre-testing and pilot testing the instrument (Tanur, 1992).   
In order to confirm the questions meet that goal they should be reviewed by 
subject matter experts and pre-tested by potential respondents.  Ideally, survey questions 
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 and statements should be short and easily read to minimize time on survey (Fink, 1995). 
The wording of the question should be such that it does not include biasing words and 
phrases and multiple phrases that relay more than one idea (Tanur, 1992).  
2.1.2 Ascertaining Attitudes 
Attitude is often used to mean opinion, belief, preference, feeling or value, and as 
a result, may be difficult to define and measure using a survey instrument. However 
scientific and technical methods are available for producing testing attitude scales that are 
valid for scientific survey needs.  The ability of the questions to obtain information on 
attitudes is evaluated by subject matter experts during the design phase.   Selection of 
pre-testers and pilot testers representative of the target audience is important.  They must 
have enough knowledge about the subject to have an opinion about it, identify gaps in 
knowledge that warrant education or publicity, and help explain attitudes and behavior 
Tanur (1992). 
2.1.3 Reliability Issues 
A reliable survey instrument is one that is relatively free of both random and 
measurement error.  Non-sampling error results from an imprecise definition of the target 
and study population and errors in survey design and measurement.  A second non-
sampling problem relates to definitions and inclusion and exclusion criteria.  Definitions 
of key survey concepts should be based on best available theory and practice; pretests and 
pilot tests can help eliminate this problem Fink (1995). 
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 Reliability is also impacted by response rate. Unsolicited surveys receive the 
lowest response rate.  A 20 percent rate is not uncommon (Fink, 1995; Hamilton, 2003; 
Kaplowitz et al., 2004).  Survey methodology must be sufficient to promote responses, 
minimize response bias, and reduce survey error.  This is done by implementing a robust 
quality assurance system that keeps the survey responses confidential and anonymous 
and by identifying a sufficiently large number of survey recipients that are actually 
interested in or knowledgeable about the topic.  Reliability is further improved by 
utilizing pretesting and pilot testing of questions during the survey design phase Fink 
(1995).   
2.1.4 Validity Issues 
Validity is the degree to which a survey instrument measures what it is purported 
to measure.  The researcher must focus on assuring both external and internal validity.  
External validity refers to the extent to which the results of the study are generalizable.  
Internal validity answers whether the survey measures what it intends to measure and is 
tested by evaluating inter-item agreement within the survey (Litwin, 1995).   
2.2 Hormesis 
2.2.1 Background 
One of the most common underpinnings of toxicology “the dose makes the 
poison” is attributed to Paracelsus, a 16th Century physician and scientist said to be the 
“Father of Toxicology”.  The saying demonstrates that throughout history many scientists 
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 have well understood the complexities of biology that occur at low doses.  In the 19th 
Century, the complexities of low-dose stimulation were evaluated in a series of 
experiments conducted by Rudolph Arndt and Hugo Schultz.  They documented the 
occurrence of biological stimulation at low doses.  Their documentation of the biphasic 
dose-response phenomenon is known as the Arndt-Shultz Law.  However, their work was 
widely overlooked possibly due to its association with the controversial medical practice 
of homeopathy (Calabrese and Baldwin, 2000a).   By the 1940’s the biphasic dose 
response became known as hormesis, a term derived from the Greek word meaning “to 
excite” (Calabrese and Baldwin, 2000b). The historic development of the concept of 
hormesis and the corresponding belief that low doses of toxins could have stimulatory 
effects at low doses was detailed in literature reviews by Calabrese and Baldwin 
(2001c,d). 
Prior to Calabrese and Baldwin’s work, (Smythe, 1967) provided a compelling 
review of adaptive responses in the toxicological literature, but did not adopt the term 
hormesis.  In his review Smythe points out that industrial hygienists were taught that the 
human body responds to acute changes with immediate re-adjustments and to repeated 
changes with adaptation.  Smythe expressed concern that protective technological 
advances were producing a generation of people so protected from environmental 
changes that they would be less able to adapt to stress.  The Smyth review, covering 
literature from 1922 through 1966, provides many examples of adaptive responses, 
increased growth, positive reproductive outcomes and increased longevity resulting from 
low dose exposures to chemicals and ionizing radiation.   
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 2.2.2 Dose-Response Models 
Evaluating, understanding, and applying concepts related to dose-response is the 
foundation of toxicology and is directly related to drug discovery and human health risk 
assessment.  Two dose-response models, threshold and linear non-threshold (LNT), are 
traditionally used by regulatory agencies and other public health policy makers, as default 
models to describe the dose-response relationship.   
The threshold model is used to assess risk posed by non-carcinogenic chemicals.  
It is based on the assumption that a threshold exists below which no adverse effects 
occur.  Toxicological studies are designed to identify that threshold.  The data yields a 
Lowest Observed Adverse Effect Level (LOAEL), No Observed Adverse Level 
(NOAEL), or Benchmark Dose (BMD) from which a “safe dose” is derived.  Threshold 
model results are input variables, along with exposure data, for conducting human health 
and ecological risk assessments.  
Regulatory agencies default to the LNT model to assess chemicals thought to be 
carcinogenic.  The model assumes that if a large quantity of a chemical will cause cancer, 
then even a molecule poses a cancer risk (Calabrese and Baldwin, 2001c,d; Calabrese and 
Blain, 2005).  The only case for which the LNT is not applied is when the chemical under 
study can be proven to have a non-genotoxic mode of action and the exact mode of action 
is known.  Then the threshold model is applied (USEPA, 2005).  The LNT model is 
carried out in 3 steps 1) high dose studies are designed and conducted to elicit a 
carcinogenic response, 2) data are evaluated to derive a point of departure (POD) near the 
low end of the observed range and 3) a curve is extrapolated from the POD to zero to 
derive a Cancer Slope Factor or Cancer Potency Factor that can be used to conduct a 
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 human health risk assessment.  The model assumes that biological response is directly 
proportional to dose without any threshold and that a negative response is always present 
down to the last molecule.   
Neither the threshold nor LNT model evaluates data in the low-dose region of the 
dose response curve.  The models were developed to fill in the data gaps that exist in the 
low dose range.  These gaps exist because toxicological studies are typically designed 
with doses sufficiently high to assure the study produces an adverse effect, if one exists.    
2.2.3 Hormesis as the Alternative Model 
Traditional assumptions about the shape of the dose response continuum are 
challenged by the concept of hormesis.  The hormetic dose response is a specific type of 
non-monotonic dose response characterized by low-dose stimulation and high dose 
inhibition.  The curve is usually described as either J (U) -shaped or inverted J (U) –
shaped where at low doses the response is opposite to that of high doses (Calabrese and 
Baldwin, 2001c,b; Calabrese and Blain, 2005). Calabrese and colleagues have developed 
two databases containing thousands of examples of hormesis.  Collectively, the data 
demonstrate the hormetic dose response is more common than the threshold and LNT 
models in head-to-head comparisons and is generalizable across a broad range of toxic 
agents, organisms and health endpoints.  
The first database contains almost 6,000 dose responses drawn from peer 
reviewed literature.  In order to be included in the database, the study had to meet the 
following a priori entry criteria: 1) strength of study design including ≥6 doses with at 
least 3 below the NOAEL, 2) magnitude of stimulation, 3) statistical significance, and 4) 
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 reproducibility of findings (Calabrese and Baldwin, 1997). Quantitative features of the 
dose responses in this database indicate hormetic stimulation (amplitude) is generally 
modest with approximately 80% of the responses showing a maximum stimulation 
approximately 30-60% greater than the control.  The stimulatory range is much more 
variable than amplitude, and extends over a dose range of 20-fold or less (Calabrese, 
2004a).   
The second database was created to address frequency of hormesis in the 
toxicological literature.  It included a priori entry criteria as well as a priori evaluative 
criteria (i.e. a well-defined NOAEL, ≥ 2 doses below the NOAEL, and the endpoint 
measured has the capacity to display either stimulatory or inhibitory responses).   From 
this database, the frequency of hormesis reported in the literature was estimated to be 
approximately 40% (Calabrese and Baldwin, 2001c).  This database was also used to 
assess which dose-response model, hormesis or threshold, occurred more often in the 
literature.  The majority of dose-responses displayed values greater than the controls.  
The hormetic model was more common than the threshold model, suggesting that the 
hormetic model may occur 2.5 times more frequently than the threshold model 
(Calabrese, 2004b; Calabrese and Baldwin, 2003a; Calabrese and Blain, 2005).   
In a comprehensive review of tumor cell literature, Calabrese found that hormesis 
occurred in over 130 tumor cell lines.  The responses were produced by a wide range of 
agents including anti-neoplastics, non-neoplastic drugs, endogenous agonists, and phyto 
compounds (Calabrese, 2005b).  Hormetic models in yeast data were observed 4 times 
more often than would be expected by chance alone (Calabrese et al., 2006). 
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 Hormetic dose response relationships have been reported by other researchers 
specializing in immunology, pharmacology and dietary restriction.  Dietary restriction is 
reported by Hayes (2006) as the most effective and reproducible laboratory intervention 
for extending lifetime survival in diverse organisms. Genome transcription analyses show 
the multiple effects antibiotics have on cells at low doses.  All antibiotics, regardless of 
receptors and mode of action, exhibit the phenomenon of hormesis and provoke 
considerable transcription activation at low concentrations (Davies et al. 2006).    It was 
proposed that many hormones and other biologicals have reverse effects in biologic 
systems depending on their dosage or concentrations and that characteristic may be useful 
for developing treatments for malignant tumors (Prehn and Berd, 2006).  
The hormesis data are so convincing that this model was recently added to a 
leading toxicological text book, Casarett and Doull’s Essentials of Toxicology (Klaassen 
and Watkins, 2003).  The hormetic effects are hypothesized to occur when relatively low 
doses result in the stimulation of a beneficial or protective (adaptive) response, such as, 
receptor activity, modulation of DNA repair, the induction of detoxification enzymes, 
and/or the induction of cellular antioxidant defense systems (Calabrese, 2005c). 
Evidence of hormesis is also reported in the epidemiological literature. Hormetic-
like dose response relationships have been observed in the epidemiology literature 
(Mundt and May, 2001).  However, Mundt and May concluded it was not possible to 
discern whether the observation was hormesis or rather the combined effect of several 
different biological or disease processes.  They provide an example of the dose-response 
relationship between alcohol and all-cause mortality.  Applying hormesis to this example 
however forces the definition to include dose response relationships that incorporate 
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 diverse causes of mortality and disease mechanisms.  Literature reviews support the 
hypothesis that hormesis is caused by diverse adaptive response mechanisms (Cook and 
Calabrese, 2006a). 
The evidence for the hormesis dose-response model and the argument the dose-
response is caused by diverse adaptive biological responses, is strengthening due to 
ongoing mechanistic research performed for drug development.  A single mechanism for 
hormesis has not been identified; however, it appears to operate within a mechanistic 
framework that is designed to conserve resources.  It may prove to be a modest 
overcompensation to a slight disruption in homeostasis (Calabrese, 2004b).  Research 
studies in biological systems have identified dozens of receptor systems that reliably 
demonstrate the hormesis dose response (Calabrese and Baldwin, 2003b; Hadley, 2003).        
The significant experimental evidence compiled by Calabrese and others, supports 
the conclusion that the hormetic dose responses are broadly generalizable, and are 
independent of biological model, endpoint measured, and stressor agent.   
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 CHAPTER 3 
STUDY METHODS 
3.1 Introduction 
This chapter presents a description of all study procedures and methods, including 
selection of the survey target population, development of the survey instrument, survey 
administration, and data analysis. 
3.2 Identification and Selection of Survey Target Population 
The goal of the study is to ascertain expert opinion and attitudes about various 
dose-response models, particularly hormesis, and to determine the characteristics of those 
who would, if permitted by the regulatory framework, take the hormesis dose-response 
into account when designing or interpreting risk assessments.  Therefore, professional 
societies whose members are known to specialize in toxicology and risk assessment were 
chosen for the study.  The target societies were the Society of Toxicology (SOT) 
(n=approximately 5,800) and the Society for Risk Analysis (SRA) (n=approximately 
3,500).    
Solicitation of participation from each society and access to the membership lists 
are described below.  A discussion of the impact of participation, or lack thereof, by the 
membership of the societies on the overall study results is provided in Chapter 5: 
Discussion of Study Results.    
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 3.2.1 Society of Toxicology 
3.2.1.1 General Description 
The Society of Toxicology provides the following description on the public 
access portion of its website www.toxicology.org . “The Society of Toxicology (SOT) is 
a professional and scholarly organization of scientists from academic institutions, 
government, and industry representing the great variety of scientists who practice 
toxicology in the U.S. and abroad. SOT is committed to creating a safer and healthier 
world by advancing the science of toxicology. The Society promotes the acquisition and 
utilization of knowledge in toxicology, aids in the protection of public health, and 
facilitates disciplines. The Society has a strong commitment to education in toxicology 
and to the recruitment of students and new members into the profession”.  
The Society of Toxicology offers several types of membership: Full, Associate, 
Postdoctoral, Graduate Student, and Honorary.   In order to become a full member, a 
toxicologist must have a defined number of years of relevant toxicology experience 
depending on highest degree obtained and sponsorship including letters of endorsement 
by three full members.  The application is then voted on by members of the SOT council 
and Membership Committee. The requirements are less stringent for Associate, 
Postdoctoral, and Student memberships, but all must demonstrate professional scientific 
activities in toxicology or be enrolled in a graduate degree program and be accepted by 
the membership committee.   The Society consists of approximately 5,800 members 
overall who have a broad range of toxicological interests including, but not limited to, the 
areas of specialization selected for the demographics portion of this study’s  
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 questionnaire.   This information on SOT member qualifications is important to 
understand for analysis of SOT responses.   
3.2.1.2 Obtaining the Membership List  
The Society was requested to endorse the study in a letter dated June 20, 2008.  
Society administrative staff indicated that the request would take several months to 
process because it would have to be approved by a newly formed Research/Meeting 
Sponsorship Committee.  The committee was not scheduled to meet until September 
2008.  SOT administrative staff indicated that because this researcher is a full member of 
the society it would be more expeditious to obtain the needed email addresses from the 
membership directory.  Therefore, the email addresses were obtained by downloading the 
membership directory from the SOT website.  The directory is only available to members 
using a society provided password.  The email distribution list that was downloaded onto 
the University list-serve consisted of 5,833 distinct email addresses.  This list includes all 
members according to SOT administrative staff.  
3.2.1.3 Obtaining Society Demographics for Comparing Study Respondents to 
Society Membership 
The representativeness of the survey research study population can be indirectly 
evaluated by comparing survey respondents’ demographic characteristics to the overall 
demographic characteristics of the complete population list of the Society.  After several 
discussions with Society administrative staff followed by a formal request letter, the 
Society provided summary statistics on the membership demographics.  A copy of the 
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 request letter is provided in Appendix A.  The data provided by SOT included the 
following information about members: gender, education, years of experience, and 
primary specialty.  The Society obtained the membership data from their annual online 
membership renewal forms.  The society does not mandate that members provide 
demographic information; it is voluntary.   
3.2.2 Society for Risk Analysis 
3.2.2.1 General Description 
The Society for Risk Analysis (SRA) provides the following self description on 
the public access portion of its website www.sra.org .  “The Society for Risk Analysis is 
an international interdisciplinary professional society devoted to risk analysis. Members 
have interests in risk analysis, risk perception assessment, risk management and risk 
communication.  The interdisciplinary make-up of the society is aimed at addressing, in 
an integrative way, emerging issues in risk analysis.  SRA consists of members who 
specialize in assessing health, ecological and engineering risks and natural hazards.  The 
society also explores policy, social and economic implications of risk issues.  SRA 
membership recruitment is targeted at a wide range of institutions including federal, state 
and local governments, industry, academic institutions, not-for-profit organizations, law 
firms and consulting groups.  SRA members include Risk Analysts, Ecological and 
Environmental Scientists, Emergency Preparedness and Response Planners, Engineers, 
Health Scientists, Government and Regulatory Officials, Journalists, Lawyers, Natural 
and Physical scientists, Policy Analysts, Public Administrators, Safety officers, Social 
and Behavioral Scientists, Toxicologists, and Transportation and Infrastructure scientists.  
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 The Society offers its approximately 3,500 members an opportunity to join any of the 
following specialty groups:  1) Biological Stressors, 2) Decision Analysis and Risk, 3) 
Dose Response, 4) Ecological Risk Assessment, 5) Economics and Benefits Analysis, 6) 
Engineering and Infrastructure, 7) Exposure Assessment, 8) Risk Communication and 9) 
Risk Science and Law.” 
3.2.2.2 Obtaining the Membership List   
The Executive Director of SRA did not respond to written requests, emails, or 
phone calls.  The email list was therefore, obtained from the online membership directory 
available to members using a Society provided username and password. The email 
distribution list that was downloaded onto the University list-serve consisted of 3,542 
distinct email addresses.   
3.2.2.3 Obtaining Society Demographics for Validity Analysis 
The SRA did not respond to repeated requests for comparative demographic 
information.  The impact of the lack of comparative data is discussed in Chapter 5: 
Discussion of Results.  
3.3 Selection of a Census Survey 
A complete census survey, in which the entire population is provided an 
opportunity to participate, was selected as the design for this study.  Use of a census 
survey eliminates concerns about potential sampling bias associated with non-probability 
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 sampling methods.  The concern with a census survey is the potential for non-response 
bias. 
3.4 Development of the Study Survey Instrument 
3.4.1 Choice of Response Category (Dichotomous vs.  Likert scale) 
The initial drafts of the survey instrument were developed using 5 point Likert 
Scale response categories following the convention of placing the negative end of the 
scale first. Numbers were assigned to the ordinal data ranked lowest to highest. However, 
it could not be determined based on the Likert Scale how participants with a negative 
(low) opinion of hormesis quantitatively compared to people with slightly negative, a 
neutral, positive (high), or highly positive opinion of hormesis.  The assumption that 
Likert scales could be treated as ordinal categories did not prove correct for this study.   
Subjective hence arbitrary decisions would have had to be made about how to re-code the 
data for logistic regression analysis.  Thus, the survey was re-written to accommodate 
dichotomous responses that would not require re-coding.  
During the pre-testing and pilot testing of the questionnaire, some reviewers 
suggested use of a Likert Scale because they felt dichotomous responses did not give 
respondents with neutral opinions a response option.  This suggestion was not adopted 
due to concerns about subjective and arbitrary re-coding of the responses. 
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 3.4.2 Questionnaire Development 
The process for revising and creating a valid and reliable survey instrument 
includes 1) initial question development, 2) pre-testing and revision, and 3) pilot testing 
and revision (Fink, 1995; Tanur, 1992).   
The goals for developing a valid questionnaire for the study were the following: 
1) make the questions concrete, precise and unambiguous, 2) assure each question 
conveyed one thought, 3) eliminate potential for biasing the respondent, 4) develop a 
questionnaire that could be answered in less than 20 minutes to keep attrition low, and 5) 
assure validity and reliability of the survey instrument.   
3.4.3 Questionnaire Documentation 
The survey was pre-tested and pilot tested by 25 toxicologists and risk assessors 
representing diverse backgrounds and employment.  After committee review and 
revision, the survey instrument was Beta tested by an independent third party Professor of 
Genetics, Toxicology, and Botany at Holy Cross University.  The suggested revisions 
were to reduce the number of questions and re-word certain questions to assure clarity of 
meaning.  The revised questionnaire was submitted to four pre-testers.  The four were 
selected based on their diverse areas of expertise; specifically, general toxicology, 
pharmacology, pharmacokinetics and health physics.  Their suggestions for wording 
changes were adopted.  None of the reviewers made substantive content changes.  The 
questionnaire was then provided to twenty toxicologists and risk assessors for pilot 
testing.  This group consisted of professionals with advanced degrees and represented all 
professional employment sectors of the target population.  The pilot test reviewers were 
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 asked to validate the assumption that the survey could be completed in the desired 
timeframe.  They were also requested to recommend questions for inclusion or deletion 
and to evaluate questions for meaning.  Specifically, they were asked to evaluate whether 
the questions and statements were clearly written, easy to understand, appropriate to the 
audience and unbiased.  They were also asked to provide suggestions for additional 
content and improvement of content.  Although the pilot study was carried out by 20 
reviewers, only 12 provided specific written comment.  The comments were focused on 
clarifying the meaning of specific questions. 
3.4.4 The Final Survey Instrument 
The final survey instrument consisted of the following: 
• Section 1: Introduction Cover Letter and Informed Consent 
• Section 2: Demographic Data 
• Section 3: Knowledge and Attitudes about Interpreting Dose-Response 
Assessments 
• Section 4: Knowledge and Attitudes about the Hormesis Dose-Response 
• Section 5: Knowledge and Attitudes About Risk Assessment Principles and 
Practice 
• Section 6: Conclusion and Request for Feedback 
 
3.4.4.1 Section 1: Introduction and Cover Letter 
Enticing respondents to complete the survey is critical to increasing response rate 
and therefore improving survey validity.  An invitation email accompanied the request to 
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 participate and survey link (Appendix B).   The survey instrument Introduction section 
repeated the purpose and goals as well as contained the informed consent notification.  
The email subject line was worded so that the potential respondent would understand that 
the subject matter was hormesis.   The email invitation and Introduction incorporated the 
following as recommended by Fink (1995):   
• Explain the purpose of the study 
• Describe who is conducting the study 
• Explain how respondents were chosen 
• Provide a realistic estimate of time to complete the survey 
• Explain how confidentiality will be protected 
• Provide the response deadline  
• Provide instructions for completing the survey 
• Provide researcher contact information 
• Provide examples of how the data will be made available to the respondents 
• Provide the informed consent 
3.4.4.2 Section 2: Demographic Data 
While the concept for this survey was being developed, it was thought that a 
respondent’s knowledge and opinions about risk assessment in general and hormesis in 
particular may vary by gender, age, education, experience, type of employment, specialty 
and subspecialty, as well as social, economic, and political views, and these variables 
were taken into account with the final selection of demographic variables for analysis.  
Further, four of the five research goals depend on obtaining and interpreting respondent 
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 demographic data.  Demographic variables were chosen based on the research goals of 
identifying characteristics of respondents which may influence attitudes towards 
hormesis when interpreting risk assessment results, and in order to be inclusive of a wide 
variety of employment areas and specialties in toxicology that could be used in the 
analysis.  
The survey was designed to keep attrition rates as low as possible by placing the 
request for demographic information at the front of the survey (Andrews et al., 2003; 
Fink, 1995).   
3.4.4.3 Documentation of Final Subject Matter Questions 
The knowledge and opinion questions are contained in Sections 3, 4 and 5.  In 
order to assist the respondent in answering the questions figures depicting the linear non-
threshold, threshold, and J-shaped hormesis dose response curves were inserted at the 
beginning of each section. Documentation of each question and the purpose for asking 
the question is presented in Appendix C.  
3.4.4.4 Final Questionnaire 
The final version of the questionnaire contained 46 coded statements, including a 
question at the beginning asking the participant if he/she had taken the survey before and 
2 open-ended questions at the end of the survey instrument asking the participant for 
comments on missed content and survey quality.  The first question “If you have taken 
this survey before, please skip to the end” was added because respondents could have 
been sent two different survey links if they were members of both SOT and SRA.  If the 
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 person answered yes to question 1, they were sent to the end page thanking them for their 
participation.     
3.5 University of Massachusetts Human Subjects Requirements 
This study was carried out in compliance with 45 CFR 46 and guidelines set forth 
by The University of Massachusetts Human Research Protection Office (HRPO).  The 
office assures protection of the rights and welfare of human subjects in accordance with 
federal regulations and the campus Federal Wide Assurance issued by the U.S. 
Department of Health and Human Services.  The study was approved by the Internal 
Review Board (IRB) on August 22, 2008.  The study qualified for expedited review 
within the School of Public Health because it involved no more than minimal risk to 
subjects.  The review was coordinated by Linda Downs-Bembury and Dr. Richard Van 
Emmerik.   
3.5.1 IRB Form and Training 
The Abstract of Research Plan, Form ADM 441 and Cover Letter submitted to the 
IRB are archived in this researcher’s academic record.  The required training in 
protection of human subjects was completed on October 14, 2007 including the required 
training module for “Social and Behavioral Research Investigators and Key Personnel” 
and the optional training module for “Internet Research.”  The Collaborative Institutional 
Training Initiative (CITI) completion certificate is archived in this researcher’s academic 
record.  The training was invaluable in assuring the questionnaire was designed to 
comply with the Belmont Principles of respect for persons, benefice and justice.   
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 3.5.2 Informed Consent 
Federal requirements followed by the University require that investigators 
conducting human research obtain the consent of the subject.  The purpose of informed 
consent is to educate potential respondents about the purpose of the study, research 
procedures, and risks and anticipated benefits of participation.  The informed consent was 
included in the Introduction section of the survey.  The purpose, risks and benefits of the 
survey were explained.   The respondents were assured that their responses would be 
confidential and anonymous.  They were offered an opportunity to ask questions and 
were provided this researcher’s telephone number and email address.  Potential 
respondents were informed they could withdraw from the survey at any time and could 
choose not to answer all questions.   Accordingly, the web based survey did not force the 
respondent to answer a question before proceeding to the next question.    
3.5.3 Privacy and Anonymity 
Protecting privacy is paramount when conducting survey research.  Web-based 
surveys provide researchers more opportunity to inadvertently violate privacy than in 
conventional surveys. For example, email pre-notification, the survey itself, and follow-
up could be considered unsolicited “spam”. The goal is to build trust to encourage people 
to participate so they do not feel “spammed” or exploited.  Therefore, the survey was 
delivered through the University list-serve from this researcher’s personal email address.   
Because the survey was being sent to a broad range of potential respondents, 
including government employees, it was designed for all responses to be anonymous, 
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 thus eliciting candid answers.  All respondents were assigned a survey ID number 
through the web-based survey tool.  The tool’s database recorded the ID tagged to a 
specific email address and the survey was entered by a link embedded in the email.  By 
separating the survey from the email, privacy issues around email (work monitored email, 
multiple users having access to password protected email accounts) were minimized. 
The only respondents who could be personally identified are those who contacted 
me personally to ask questions or make comments.  Even in such a situation, their 
responses remained anonymous because they were maintained in the separate third party 
database.  Protection of privacy is further discussed in the following section, survey 
administration. 
3.6 Survey Administration 
3.6.1 SurveyMonkey® 
The SurveyMonkey ® tool was chosen for survey administration because 1) there 
is extensively documented research indicating that it protects respondent privacy and 
anonymity, and 2) respondents may have familiarity with this tool because it is used 
extensively by professional societies to administer opinion surveys and for distributing 
ballots for voting on candidates for various society and specialty section elections.  
The weblink “collector” provided by SurveyMonkey ® for each distribution list 
allowed only one response per unique link and enabled IP address blocking so the survey 
could not be sent from the recipient to others who were not members of either SOT or 
SRA.  SurveyMonkey® has established a strong privacy policy and anti-spamming 
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 agreement. Therefore, the email and survey link contained an “opt out” remove link field 
so that reminders would not be forced upon an unwilling recipient.   
3.6.2 Distribution and Reminders 
Separate email list-serve distribution lists were established for each of the two 
societies.  The survey was distributed via email to 9,375 potential respondents, all of 
whom were members of either the Society of Toxicology (n=5,833) or the Society for 
Risk Analysis (n=3,542).  The initial invitation to participate was emailed on August 26, 
2008.  Reminders were sent on September 9th and September 24th.  The survey closed on 
October 7, 2008. 
3.7 Data Analysis 
3.7.1 Introduction 
The goal of the data analysis was to identify relationships between variables, to 
make comparisons between demographic groups and other logical groupings of variables, 
and ultimately to determine how acceptance or rejection of hormesis relates to knowledge 
of the subject, predisposing values, or demographic characteristics.  The analysis for this 
study was carried out in several stages as described below.  
3.7.2 Data Management and Variable Codes 
Descriptive statistics provided by SurveyMonkey ® were downloaded and are 
summarized in tables in Chapter 4.  The raw data were downloaded from 
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 SurveyMonkey® as comma separated value (CSV) ASCII text files.  SAS software, 
version 9.2 SAS Institute, Inc, Carey, NC was used to convert the CSV files into a single 
SAS data set containing all question responses, comments, and metadata, such as survey 
start and end times and the unique respondent ID assigned by the SurveyMonkey ® tool. 
Data management included the following:  
1) Removing invalid responses and duplicate survey returns.  SurveyMonkey ® 
retains a record of everyone who opened the survey but did not answer any 
questions.  These subjects were removed from the database prior to any analysis.  
Because a respondent could have received the survey from both distribution lists, 
as described above, duplicate survey returns were removed by treating returns 
with identical gender, state of residence, and date of birth as a duplicates.   
2) People who completed the demographic portion of the survey and answered at 
least one of the first five questions in Section 3 were categorized as respondents.  
3) Logical groupings of demographic characteristics were developed to facilitate 
analysis.  Examples include, but are not limited to, work experience categories 
(based on years of experience), employment type (e.g. industry, academia, and 
government), and specialty type (e.g. combining reproductive and developmental 
specialties).   
4) Additional variables were created for time spent on survey by the study 
participant and whether a respondent completed the survey.  The survey was 
considered complete if the respondent answered any of the last four survey 
questions.    
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 3.7.3 Descriptive Statistics 
Respondent characteristics of all validated data were summarized for all 
demographic variables, type of employment and specialty. Overall response rate and 
response rate by society membership were calculated.  Completion rate was calculated by 
the key demographic variables of gender, professional society membership and 
education.    
3.7.4 Univariate and Joint Analysis  
The textbook Biostatistics: A Foundation for Analysis in the Health Sciences 
(Daniel, 1995) and the SAS Procedures Guide, Version 6, Third Edition (SAS, 1990) 
served as the basic foundation for identifying the appropriate statistical tests to apply to 
the data.  Odds ratios (OR) with 95% confidence intervals (CI) estimated through logistic 
regression analysis were used to identify demographic characteristics of those who 
accept/reject hormesis and to identify the characteristics of subjects most likely to use 
hormesis for risk assessment.  
 
3.7.4.1 Tests for Association 
The chi-square test statistic was used to compare frequencies for categorical 
variables (Daniel, 1995, p. 516).   The test chi-square test compares observed frequencies 
to expected frequencies.  Examples of null hypotheses for this study are:  no difference 
between male and female respondents, no difference between educational categories, and 
no difference between various employment categories.  The chi-square output was 
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 scanned to identify significant (p<0.05) heterogeneity in responses among and between 
demographic variables.   
3.7.4.2 Univariate Analyses of Associations 
The variables that were found to be statistically significant across most questions 
were further evaluated by calculating odds ratios to examine the odds that a category of 
respondents agreed or disagreed with the idea asked by the policy questions described 
below.  Frequency data were entered into 2x2 tables.  Respondents were dichotomized 
(e.g. male/female, SOT/SRA, EverEPA/All other employers) with respect to whether 
they agreed or disagreed with the question.  The OR along with its 95% CI was 
calculated using standard methods (Daniel, 1995, p.547). 
Evaluation of statistical significance was accomplished by examining the upper 
and lower bounds of the 95% CI.  If the lower bound of the CI was >1.0 or the upper 
bound was <1.0, then the estimated odds ratio was deemed statistically significantly 
different from the null odds ratio of 1.0.   
3.7.4.3 Multivariate Analyses 
The logistic regression model is employed when the dependent variable is 
dichotomous. Logistic regression allows one to estimate the ORs for several variables of 
interest, permitting the identification of variables that remain significantly associated 
with the dependent variable when adjusted for the effects of other candidate covariates.   
It is the most widely used statistical model for evaluating several characteristics which 
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 are independently associated with a particular dichotomous outcome (Daniel, 1995, p. 
484). 
Logistic regression modeling was carried out only on the questions of interest 
described below.  For those questions ORs with upper and lower bounds satisfying the 
criteria for statistical significance were included in a logistic regression model to 
determine the characteristics associated with the “agree” response in a multivariate 
analysis.   A step-wise model was developed for variables that might be highly correlated 
such as the general categorical variable employment at a regulatory agency and specific 
categorical variable employment at the USEPA.   
3.7.5 Selecting Specific Questions for Univariate and Multivariate Analysis  
All questions in the survey instrument are important for gaining an understanding 
of respondents overall knowledge and opinions about risk assessment and the hormesis 
dose-response.  Four questions were singled out for detailed analysis because they 
provided answers to the specific research question regarding who would take hormesis 
into consideration when designing or interpreting risk assessments.   The selection of four 
“policy questions” is described below. 
The first policy question is number 32.  It covers the basic tenants of review 
papers and original research published by Calabrese and others that sufficient data exist 
to suggest hormesis occurs in a wide range of species and endpoints following low-dose 
exposure to a broad range of chemical agents and physical stressors.   
The second policy question is number 36.  It was designed to evaluate whether 
hormesis could be accepted in risk assessment to obtain potential benefit.   This question 
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 is meant to get to the heart of the hormesis debate detailed in Chapter 2: Review of the 
Literature.   Question 36 was also selected for comment analysis.  An a priori concern of 
the research committee was that only people with a strong positive or negative opinion 
about hormesis would take the time to answer a detailed questionnaire on the topic.  This 
question was selected for comment analysis because EPA guidance specifically states 
benefit cannot be taken into account when determining a safe dose (EPA, 2004) thus, this 
question more than the others could have elicited a “passionate” comment.  
The third policy question is number 38.  Many regulations in place today are 
based on the linear non-threshold and threshold dose-response models.  Question 38 asks 
the respondent to consider a situation in which hormesis is the default model for risk 
assessment.  The question serves as an important indicator of the impact hormesis could 
have on the regulatory framework. 
The fourth policy question is number 39.  This question asks the participant to 
consider the current state of knowledge about hormesis and provide an opinion as to 
whether the phenomenon justifies a change in hazard assessment methodology.  The 
question is an important indicator of the impact hormesis could have on the design of 
dose-response experiments. 
In addition to the four policy questions, there was also interest in evaluating how 
respondents with direct experience in dose-response research and who reported observing 
one or more of the various dose-response curves pictured in the questionnaire,  viewed 
the four policy questions.  Therefore the response to question 26 which asks a respondent 
to report how commonly he/she has observed hormesis was compared with whether the 
respondent agreed to questions 32, 36, 38 and 39.  
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 3.7.6 Internal Consistency Analysis 
Measures of internal consistency answer whether the survey measures what it 
intends to measure.  It is tested by evaluating inter-item agreement within the survey.  
Chronbach’s Coefficient Alpha is a statistical measure of internal reliability commonly 
used to assess survey instruments.  It is applied to groups of questions designed to 
measure different aspects of the same concept.  Although single items may be quicker to 
administer, the data set is richer and more reliable if several different items are used to 
gain information about a particular attitude or opinion (Litwin, 1995).  The calculation of 
Alpha statistical test to evaluate internal consistency was carried out using standard 
equations and procedures (SAS Procedures Guide, 1990). 
Two tests for internal consistency were built into the questionnaire.  The 
following questions were designed to take one or more measures on the subject’s attitude 
or knowledge about a particular risk assessment, policy or hormesis topic.  The first test 
was disagree response to question 15 vs. an agree response to question 19.  Both evaluate 
the respondent’s opinion on the current dose response default model for cancer risk 
assessment.   The second test was agree response to question 31 vs. an agree response 
question 41.  Both indicate whether the respondent shows a consistent understanding of J-
shaped dose-response curve depicted in the figures.    
3.7.7 Evaluation of Response Bias 
In order to address concerns about response bias the characteristics of those who 
completed the survey were compared to those who dropped out along the way.  Chi-
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 square tests were used to identify statistically significant differences by demographic 
variable.      
Auxiliary information provided by SOT was used to compare the overall 
demographic characteristics of the entire membership of the society to the demographics 
of study respondents.  This analysis was also used as an indirect assessment of external 
validity in assessing whether the survey results may be generalizable to the survey target 
population and participating societies.    
An independent study provided by researchers conducting a similar survey on the 
SOT membership three months after the present survey was also used to evaluate validity 
of overall study results. 
The research committee suggested coding comments to Questions 36, 45 and 46 
as to whether they were negative, neutral, or positive toward hormesis in an effort to 
indirectly evaluate response bias.  It is acknowledged that this coding is subjective.  For 
the purposes of this study, if comments were overwhelmingly positive or negative, over 
20% in either direction, it was concluded response bias could be present. If however, the 
overwhelming majority of comments, 80%, were neutral then it was concluded response 
bias may be low. 
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 CHAPTER 4 
RESULTS 
4.1  Introduction 
This chapter presents the study results.  The order of presentation follows the 
methods outlined in Chapter 3, beginning with summary of response rate, completion 
rate, respondent characteristics, and descriptive statistics for each question.  This is 
followed by univariate and multivariate logistic regression analysis of the four policy 
questions and the dose-response research question, internal consistency analysis and 
evaluation of potential response bias.  Interpretation and discussion of findings are in 
Chapter 5.  
4.2  Descriptive Statistics 
4.2.1  Response Rate 
The internet survey invitation link was sent via email to 5,833 Society of 
Toxicology members and 3, 542 Society for Risk Analysis members.  SurveyMonkey® 
recorded a total of 1,882 potential respondents opening the email link. Of that number, 
1,326 opened the SOT survey link providing an overall response rate of 23%; and 556 
opened the SRA survey link providing an overall response rate of 16%.  All 1,882 
responses were downloaded into the SAS database as described in Chapter 3.  The 
questionnaires with missing data (n=221) and duplicates (n=15) were removed.   The low 
number of duplicates suggests few respondents attempted to answer the survey more than 
once as a result of receiving two invitations, one from each of the two distribution lists.  
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 The adjusted response rates after missing and duplicates were removed are 20% and 14%, 
respectively.  A total of 183 subjects completed the demographic portion of the survey, 
but did not answer the remaining questions.  These 183 subjects tended to be female 
(14% were female vs. 8% who were male), belong to the Society for Risk Analysis (14% 
were members of SRA vs. 10% who were members of SOT), and have less experience 
(16% had 0-9 years of experience vs. 5% who had over 30 years of experience).  The 
response rate adjusting for people who stopped the survey after the demographics section 
was 18% (n=1, 045) for SOT and 12% (n= 418) for SRA.  Overall and adjusted response 
rates are presented in Figure 4.1.  Subjects who completed the demographic questions 
and answered at least one of the first four subject matter questions (questions 14 -17) 
were classified as respondents.  Twenty-three email addresses (6 for SOT and 17 for 
SRA) were returned as undeliverable.  This was not enough to materially affect the 
response rate for either society.  The list-serve recorded over 200 bounces, automatic 
replies such as out of office indicators.  These bounces were not considered undeliverable 
in calculating response rate because it is possible that the subject could have eventually 
opened the survey link and answered the questionnaire, provided they returned to their 
email prior to survey close on October 7, 2008. Because the survey was anonymous, it is 
not known whether the bounced email recipients answered the questionnaire.  
Most respondents completed the questionnaire on or near the dates of the initial 
invitation or on or near the dates of the reminders as shown in Figure 4.2. 
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Society of Toxicology (SOT)
n=5,833 valid email addresses
Society for Risk Analysis (SRA) 
n=3,542 valid email addresses
SOT
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SRA
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SOT
n = 1,326
Response = 23%
SRA
n = 556
Response = 16%
Linked to Survey
n=1,882
Responses
n=1,646
Remove surveys with all missing data (n=221)
Remove duplicate surveys (n=15)
.
.
Invitation Link via eMail
n=9,375
.
Respondents
n=1,463
Remove Respondents who answered demographic section only (n=183)
SOT
n = 1,045
Response = 18%
SRA
n = 418
Response = 12%
 
 
Figure 4.1: Flow diagram of overall response rate and adjusted response rate 
 
  
4.2.2 Completion Rate 
4.2.2.1 Completion Rate by Question 
Completion rate was evaluated by question and by demographic variables of 
interest.  Completion rate by question was calculated based on the 1,463 respondents who  
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Figure 4.2: Frequency diagram of questionnaire responses by date.  The spikes 
correspond with initial invitation 8/26 and subsequent reminder dates of 9/8 and 
9/24 
 
completed the demographic section and continued the survey through question 43.  
Completion rate by question, starting with question 14 is presented in Table 4.1.    
4.2.2.2 Completion Rate by Demographic Variables of Interest 
  Completion rate was plotted by years of experience and gender. To be 
considered complete, the respondent must have continued the survey through question 
42, 43, or 44.  Experienced men tended to have a higher completion rate in most 
categories of years of experience than women. The only exception was for women with 
10-19 years experience (Figure 4.3).   
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 Table 4.1: Completion rate by question 
 
Question Responses % 
Complete 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
1483 
1411 
1435 
1437 
1444 
1392 
1410 
1410 
1412 
1320 
1225 
1442 
1143 
1383 
1345 
1196 
1347 
1320 
1217 
1315 
1251 
1101 
1245 
1291 
1235 
1230 
1186 
1239 
1247 
1234 
1150 
100 
95 
96 
97 
97 
94 
95 
95 
95 
89 
83 
97 
77 
93 
91 
81 
91 
89 
82 
87 
84 
74 
84 
87 
83 
83 
80 
83 
84 
83 
78 
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Figure 4.3: Completion rate by years of experience and gender 
 
 
On average, the SOT and SRA response rates differed by society with the SOT 
response rate consistently higher regardless of years of experience. Response rates for 
both societies increased with increased years of experience (Figure 4.4). 
Completion rates were examined by years of experience and by highest attained 
degree (Figure 4.5).  The respondents with bachelor and master degrees tended to have 
lower completion rates, except among those with the highest years of experience.  
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Figure 4.4: Completion rate by years of experience and society membership 
 
 
Chi-square tests and multivariate regression analysis of the variables of interest 
(gender, society membership, highest attained degree, and years of experience) indicate 
subjects who completed the survey are not statistically different from those who started 
the survey.  The only statistically significant variable was 0-9 years experience. The 
multivariate logistic regression analysis results are shown in Table 4.2. 
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Figure 4.5: Completion rate by experience and highest degree attained 
 
  
Table 4.2: Multivariate logistic regression analysis results comparing subjects who 
completed the survey to those who did not complete 
 
Completed 
Survey 
Did not 
Complete  
Covariate 
No.            %        No.           %     
Adjusted 
 Odds Ratio 
95% CI 
Adjusted OR 
Gender 
  Male       
  Female                            
Education 
  PhD 
  BS, MS, JD, MD, 
DVM 
Society 
  SOT 
  SRA 
Experience 
 30 or more Years 
  0-9 Years 
10-19 Years 
20-29 Years 
 
863 
385 
 
1004 
264 
 
 
921 
352 
 
299 
351 
274 
344 
 
88 
86 
 
88 
85 
 
 
88 
84 
 
90 
85 
87 
87 
 
120   
62 
 
142 
46    
 
 
124 
66 
 
32 
63 
41 
53  
 
12 
14 
 
12 
15 
 
 
12 
16 
 
10 
15 
13 
13 
 
1.00 
0.99 
 
1.00 
1.11 
 
 
1.00 
0.78 
 
1.00 
0.58 
0.80 
0.76 
 
Reference 
0.70, 1.40 
 
Reference 
0.76, 1.64 
 
 
Reference 
0.55, 1.11 
 
Reference 
0.36, 0.94 
0.48, 1.35 
0.47, 1.24 
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 4.2.3  Respondent Characteristics 
Examination of demographic variables allows for characterization of respondents.  
Respondent characteristics are summarized for all demographic variables, type of 
employment and specialty for the 1,463 people who answered the subject matter content 
questions of the questionnaire.  Table 4.3 (top panel) provides a summary of the 
demographic variables by society.  The table shows that among respondents gender 
distribution is identical between societies.  The SRA respondent group had fewer PhD’s 
but more master’s degrees for highest attained degree.  The frequency distributions by 
society for political, economic, and social views (Table 4.3 bottom panel) were for the 
most part remarkably similar among respondents from the different groups.   
Examination by type of employment and society membership shows considerable 
similarity.  The largest differences are seen between society members ever employed by 
the pharmaceutical industry and members ever employed in environmental consulting 
(Table 4.4). 
Comparison of specialties by society shows the fundamental differences in society 
membership as described in Chapter 3 (Table 4.5).  The SOT respondent group consists 
of subjects who specialize in general toxicology with a variety of toxicological sub-
specialties.  The SRA respondent group consists mainly of subjects with specialties in 
risk assessment, policy, and public health. 
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 Table 4.3: Summary of demographic and political, economic, and social views by 
society 
 
 
 
Society of Toxicology Society for Risk Analysis Characteristic 
No. % No. % 
Gender 
  Male 
  Female 
Education 
  Bachelor’s 
  Master’s 
  PhD 
  MD/JD/DVM 
Experience in Years 
  0-9 
  10-19 
  20-29 
  ≥ 30 
 
739 
338 
 
52 
93 
924 
31 
 
331 
220 
279 
269 
 
68.6 
31.4 
 
4.7 
8.4 
83.8 
2.8 
 
30.1 
20.0 
25.4 
24.5 
 
281 
130 
 
17 
96 
288 
15 
 
85 
98 
142 
92 
 
68.4 
31.6 
 
4.0 
22.9 
68.6 
3.6 
 
20.4 
23.5 
34.1 
22.1 
 
Political Issues 
  Conservative 
  Middle of the Road 
  Liberal 
  Choose not to Respond 
Economic Issues 
  Conservative 
  Middle of the Road 
  Liberal 
  Choose not to Respond 
Social Issues 
  Conservative 
  Middle of the Road 
  Liberal 
  Choose not to Respond 
 
 
150 
466 
397 
82 
 
278 
558 
190 
 67 
 
141  
445  
431  
75 
 
 
13.7 
42.6 
36.3 
7.5 
 
25.4  
 51.1  
 17.4  
 6.1 
 
12.9 
40.8 
39.5 
6.9 
 
 
52 
157 
176 
33 
 
105  
192  
 92  
 27 
 
47  
120  
223  
27 
 
 
12.4 
37.6 
42.1 
7.9 
 
25.2  
46.2  
22.1  
6.5 
 
11.3  
28.8  
53.5  
 6.5 
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Table 4.4: Summary of responses for employment area by society 
 
Society of Toxicology Society for Risk Analysis Characteristic 
No. %1 No. %1 
Government 
  NASA 
  EPA 
  OSHA 
  CDC 
  DOE 
  FDA 
  State 
  International 
  Other 
Industry 
  Pharmaceutical 
  General Manufacturing 
  Defense 
  Petrochemical 
  Chemical 
  Environmental Consulting 
  Toxicological Consult/Res. 
Academic 
  Administrative 
  Faculty 
  Medical Faculty 
  Post-Doctoral Researcher 
  Graduate Student 
Other 
  Non-governmental Org 
  Retired 
 
. 
95 
2 
12 
11 
29 
36 
13 
57 
 
225 
34 
5 
31 
90 
58 
223 
 
27 
279 
36 
80 
85 
 
43 
65 
 
. 
8.6 
0.2 
1.1 
1.0 
2.6 
5.2 
1.2 
5.2 
 
20.4 
3.1 
0.5 
2.8 
8.2 
5.3 
20.2 
 
2.5 
25.3 
3.3 
7.3 
7.7 
 
3.9 
5.9 
 
3 
56 
2 
3 
14 
13 
33 
10 
30 
 
12 
8 
11 
13 
18 
98 
71 
 
14 
104 
7 
16 
18 
 
24 
28 
 
0.7 
13.3 
0.5 
0.7 
3.3 
3.1 
7.9 
2.4 
7.1 
 
2.9 
1.9 
2.6 
3.1 
4.3 
23.3 
16.9 
 
3.3 
24.8 
1.7 
3.8 
4.3 
 
5.7 
6.7 
1 Frequencies do not add up to 100% because the respondent was able to select all 
employment categories that applied to their career experience 
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Table 4.5:  Summary of responses by field of specialty 
 
Society of Toxicology Society for Risk Analysis Specialty 
No. %1 No. %1 
General Toxicology 
Risk Assessment 
Regulatory Policy 
Mechanistic 
Carcinogenesis 
Pharmacology 
Public Health 
Molecular 
Developmental/Reproductive 
Occupational 
Inhalation/Respiratory 
Neurotoxicology 
Immunotoxicology 
Biological Modeling 
Pathology 
Dermal 
Veterinary 
Ecology 
Food Safety 
783 
411 
174 
275 
230 
214 
144 
202 
196 
112 
151 
156 
120 
77 
78 
49 
49 
33 
100 
71.1 
37.3 
15.8 
25.0 
20.9 
19.4 
13.1 
18.3 
17.8 
10.2 
13.7 
14.2 
10.9 
7.0 
7.1 
4.4 
4.4 
3.0 
9.1 
159 
361 
151 
36 
62 
16 
144 
20 
23 
65 
45 
22 
9 
55 
9 
13 
8 
40 
47 
37.9 
86.0 
36.0 
8.6 
14.8 
3.8 
34.3 
4.8 
5.5 
15.5 
10.7 
5.2 
2.1 
13.1 
2.1 
3.1 
1.9 
9.5 
11.2 
1 Frequencies do not add up to 100% because the respondent was able to select all 
employment categories that applied to their career experience.  
 
 
4.2.4 Summary Statistics by Question 
Summary statistics for Section 3: Knowledge and Attitudes about Interpreting 
Dose-Response Assessments; Section 4: Knowledge and Attitudes about the Hormesis 
Dose-Response; and Section 5: Knowledge and Attitudes about Risk Assessment 
Principles and Practice were calculated based on responses from the 1,463 subjects who 
continued the questionnaire after completing the demographic section.  In all cases the 
summary statistics were calculated for responses only and do not include missing values.   
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4.2.4.1 Knowledge and Opinions about Interpreting Dose-Response Assessments 
Section 3 contained thirteen knowledge and opinion questions meant to ascertain 
respondent attitudes about interpreting dose-response assessments. The first of the 
thirteen questions was a basic statement that dose-response assessment is the necessary 
foundation for risk assessment.  The statement was met with virtually unanimous 
agreement (98%).  The respondents generally disagreed (75%) with the current approach 
used by regulatory agencies to assess cancer risks.  Respondents were closely split as to 
whether exposure to genotoxic carcinogens (57% agree vs. 43% disagree) or ionizing 
radiation (52% agree vs. 48% disagree) always leads to increased risk of developing of 
cancer regardless of how low the dose.  Respondents disagreed for the most part (80%) 
that non-genotoxic carcinogens always lead to increased risk of cancer regardless of how 
low the dose.  The section contained three questions about definitions of the threshold, 
linear non-threshold, and hormesis dose-response models.  Respondents generally agreed 
(> 80%) with each definition provided.  Most respondents (69%) think non-carcinogenic 
toxicants act in a manner consistent with the threshold dose-response model and over half 
(53%) think carcinogenic compounds follow the threshold model.  At the end of the 
section respondents were asked to report their first-hand experience with various dose-
response models.  The threshold dose-response was reported to be observed commonly 
and occasionally (n=1019), followed by linear-non-threshold (n=629) then hormesis 
(n=555).  Many who conduct dose-response research (n=233) commented that most 
studies are not designed to detect hormesis.  The summary results for this section are 
found in Table 4.6. 
 
 Table 4.6: Summary statistics for Section 3 “Knowledge and Attitudes about Interpreting Dose-Response Assessments.” 
 
Question Responses 
Q14. Dose-response assessment is a necessary foundation for understanding risk 
assessment. 
Agree 
 98% (1457) 
Disagree 
 2% (26) 
Q15. Regulatory upper-bound characterizations used in cancer risk assessments provide 
accurate estimates of the probability of developing cancer at low doses. 
Generally  Agree  
25% (358) 
Generally Disagree  
75% (1053) 
Q16. Exposure to a genotoxic carcinogen, no matter how small, theoretically results in an 
increased cancer risk. 
Generally Agree 
57% (827) 
Generally Disagree 
43% (608) 
Q17. Exposure to a non-genotoxic carcinogen, no matter how small, theoretically results 
in an increased cancer risk. 
Generally Agree 
20% (285) 
Generally Disagree 
80% (1152) 
Q 18. Exposure to ionizing radiation (e.g. x-rays), no matter how small, theoretically 
results in increased cancer risk. 
Generally Agree 
52% (745) 
Generally Disagree 
48% (699) 
Q19. The linear model employed in cancer risk assessment overstates risk in the low dose 
zone. 
Generally Agree 
83% (1157) 
Generally Disagree 
17% (285) 
Q20. The threshold dose-response assumes no treatment related responses occur below the 
estimated threshold. 
Generally Agree 
80% (1122) 
Generally Disagree 
20% (288) 
Q21. The linear non-threshold (LNT) dose-response assumes a biological response is 
directly proportional to dose in the low dose zone. 
Generally Agree 
88% (1247) 
Generally Disagree 
12% (163) 
Q22. The hormesis dose-response exhibits biological responses at low doses that are 
opposite to those observed at higher doses, leading to either a J-shaped or inverted U-
shaped dose-response curve. 
Generally Agree 
93% (1318) 
Generally Disagree 
7% (94) 
Q23. For effects other than carcinogenesis, most toxicants act in a manner consistent with 
the following model: 
Threshold  
69% (907) 
LNT 
14% (188) 
Hormetic 
17% (225) 
Q24. Carcinogens typically act via the following dose-response model: Threshold  
53% (649) 
LNT 
34% (414) 
Hormetic 
13% (162) 
Q25. Have you ever conducted experimental research in dose-response? Yes 65% (946) No 35% (496) 
Q26 a. In my research biological responses that best fit the threshold model are observed: Commonly 
68% (759) 
Occasionally 
23% (260) 
Rarely 
6% (63) 
Never 
3% (39) 
Q26 b. In my research biological responses that best fit the linear non-threshold model are 
observed: 
Commonly 
22% (237) 
Occasionally 
36% (392) 
Rarely 
28% (309) 
Never 
14% (153) 
Q26 c. In my research biological responses that best fit the hormesis model are observed: Commonly 
12% (127) 
Occasionally 
39% (428) 
Rarely 
33% (366) 
Never 
16% (171) 
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 4.2.4.2 Knowledge and Opinions about Interpreting the Hormesis Dose-Response 
Section 4 contained seven questions about the subject’s knowledge and attitudes 
regarding hormesis dose-response.  The first question was a query to ascertain how many 
respondents learned of hormesis in person by attending a seminar, workshop, conference 
or classroom instruction.  Most respondents had no experience with any type of personal 
instruction on the topic.   The second question asked about how commonly the 
respondent thought hormesis is reproducibly observed in a variety of study types.  Most 
respondents either thought hormesis occurred 5-20% of the time (approximately 25% of 
respondents) or selected “do not know” (approximately 35% of respondents).  Of the 
respondents who selected “do not know” 60% thought hormesis had not been adequately 
studied.  The remaining questions in the section addressed the interpretation of dose-
response models.  A large majority (86%) thought biological responses to toxicant and 
radiation exposure were not necessarily adverse.  A majority (64%) also thought the J-
shaped dose response could implicate beneficial effects at low doses.  Question 32, the 
first of four policy questions made the statement that sufficient data exist to suggest 
hormesis occurs in a wide range of species and endpoints following low-dose exposure to 
a broad range of chemical agents and physical stressors.  Respondents were evenly 
divided on the topic.  This question is analyzed in detail later in this chapter in the section 
on univariate and joint analysis.  The last question of the section asked about the 
interpretation of the hormesis dose-response.  A majority (71%) thought that the 
phenomenon of hormesis was either beneficial or harmful, depending on the biological 
response.  The responses to all questions in this section are summarized in Table 4.7.
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Table 4.7: Summary statistics for Section 4 “Knowledge and Attitudes about the Hormesis Dose-Response” 
 
Question Responses 
Q27 a. Have you ever attended a hormesis seminar? Yes 34% (461) No 66% (904) 
Q27 b. Have you ever attended a hormesis workshop? Yes 10% (126) No 90% (1201) 
Q27 c. Have you ever attended a hormesis conference? Yes 7% (92) No 93% (1241) 
Q27 d. Have you ever attended classroom instruction on hormesis? Yes 25% (327) No 75% (998) 
Q28 a. How commonly do you think hormesis is reproducible observed 
in chemical toxicity studies? 
(>60%) 
4%  (60) 
(20-60%) 
21% 
(277) 
(5-20%) 
29% (388) 
(1-5%) 
18% 
(239) 
(~0%) 
3%(47) 
Don’t 
Know 
25% (330) 
Q28 b. How commonly do you think hormesis is reproducible observed 
in chemical carcinogen studies? 
(>60%) 
2% 
(28) 
(20-60%) 
13% 
(176) 
(5-20%) 
26%  
(345) 
(1-5%) 
23% 
(303) 
(~0%) 
5%  
(67) 
Don’t 
Know 
31% (418) 
Q28 c. How commonly do you think hormesis is reproducible observed 
in ionizing radiation studies? 
(>60%) 
4%  
(54) 
(20-60%) 
19% 
(254) 
(5-20%) 
21%  
(277) 
(1-5%) 
16% 
(215) 
(~0%) 
5%  
(67) 
Don’t 
Know 
35% (467) 
Q28 d. How commonly do you think hormesis is reproducible observed 
in human epidemiology studies? 
(>60%) 
3%  
(36) 
(20-60%) 
14% 
(188) 
(5-20%) 
22%  
(290) 
(1-5%) 
17% 
(230) 
(~0%) 
6%  
(87) 
Don’t 
Know 
38% (500) 
Q29. If you answered (5-20%),(1-5%), (~0%), or do not know, to the 
preceding question is it because you believe hormesis : 
Does not occur 
2% (21) 
Not adequately 
studied 
60% (715) 
Is an exception 
20% (240) 
Not apply 
18% (220) 
Q30. Any reproducible biological response to a toxic chemical or 
radiation exposure qualifies as an “adverse effect.” 
Agree 
14% (188) 
Disagree 
86% (1159) 
Q31. If a study reliably shows a J-shaped dose-response curve, it implies 
low dose effects could be beneficial. 
Agree 
64% (843) 
Disagree 
36% (477) 
Q32. Sufficient data exist to suggest hormesis occurs in a wide range of 
species and endpoints following low-dose exposure to a broad range of 
chemical agents and physical stressors. 
Generally Agree 
48% (584) 
Generally Disagree 
52% (633) 
Q33. If a study reproducibly demonstrates the hormesis dose-response, 
the implication for low doses would be the effects are: 
Likely Harmful 
2% (20) 
Beneficial or 
Harmful 
71% (937) 
Likely 
Beneficial 
15% (203) 
Not Likely to be 
Significant 
12% (155) 
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 4.2.4.3 Knowledge and Opinions about Risk Assessment Principles and Practice 
Section 5 consisted of eleven questions on risk assessment principles and practice.  
This section contained three policy questions.  The policy questions are examined first, 
followed by the results of the remaining principles and practice questions. 
Question 36 presented the statement “risk assessment procedures should be modified to 
obtain potential benefits associated with hormesis.”  The questions was also selected for 
detailed comment analysis because it was thought this question might elicit the most 
“passionate” response from subjects.  The comments are summarized in a later section of 
this Chapter.    A majority (68%) agreed that risk assessment procedures should be 
modified to identify potential benefit.   Question 38 was the third policy question and it 
probed whether respondents would be willing to re-evaluate current regulations if the 
hormesis dose-response was accepted as the default model for risk assessment.  Seventy-
seven percent of respondents agreed that if hormesis were accepted as the default model 
for risk assessment, regulations should be re- evaluated.  The last policy question, number 
39, stated “the phenomenon of hormesis justifies a change in hazard assessment protocols 
(e.g. sample size, number of doses, timing of doses).  A 65% majority agreed with this 
statement.  Further analyses of all the policy questions are presented in the univariate and 
multivariate analysis of policy questions presented later in this chapter.  
Although important in gaining an overall understanding of study respondent 
knowledge and attitudes about risk assessment principles and practice, the remaining 
questions did not undergo detailed analysis and are summarized in this section and 
discussed in Chapter 5.  Questions 34 and 35 asked about respondent attitudes toward 
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chemical and ionizing radiation regulations.  A majority (56%) thought current chemical 
regulations were reasonable and a larger majority (78%) thought ionizing radiation 
regulations were reasonable. In response to question 37, most (88%) thought hormesis 
should be subjected to the traditional use of safety factors.  The remaining questions 
covered a variety of risk assessment topics.  The responses to question 42 indicated 71% 
think hormesis would not reduce the need for uncertainty factors.  Responses to questions 
40, 41, 43, and 44 indicate that most respondents generally agree that hormesis could 
have a practical use in the conduct of risk assessment.  The responses to all questions in 
this section are summarized in Table 4.8. 
4.3 Tests for Association 
Chi-square tests, odds ratios, and multivariate logistic regression modeling were used to 
identify characteristics of those who would accept or reject hormesis and to predict those 
who would use hormesis in the conduct of risk assessments.  This section provides an 
examination of the four questions that were singled out for detailed analysis (questions 
32, 36, 38 and 39).  The selection criteria for each question are discussed in Chapter 3: 
Methods.  This section starts with an explanation of how variables were selected for 
univariate analysis and then details the univariate and multivariate analysis results for 
each question. 
 Table 4.8: Summary statistics for Section 5 “Knowledge and Attitudes about Risk Assessment Principles and Practice”  
 
Question Responses 
Q34. What is your perspective on the current state of chemical regulation? Too Stringent 
19% (239) 
Reasonable 
56% (698) 
Not stringent 
enough 
25% (314) 
Q35. What is your perspective on the current state of ionizing radiation regulations? Too Stringent 
13% (143) 
Reasonable 
78% (855) 
Not stringent 
enough 
9% (103) 
Q36. Risk assessment procedures should be modified to obtain potential benefits associated 
with hormesis. 
Generally Agree 
59% (728) 
Generally Disagree 
41% (517) 
Q37. If a chemical exhibits a hormesis dose-response, the risk assessment should 
accommodate the data. 
Generally Agree 
88% (1128) 
Generally Disagree 
12% (163) 
Q38. If hormesis were accepted as the default model for risk assessment, current 
regulations should be re-evaluated. 
Generally Agree 
77% (950) 
Generally Disagree 
23% (285) 
Q39. The phenomenon of hormesis justifies a change in hazard assessment protocols (e.g. 
sample size, number of doses, timing of doses). 
Agree 
65% (797) 
Disagree 
35% (433) 
Q40. Acceptance of hormesis decreases the margin of safety in risk assessments. Generally Agree 
29% (346) 
Generally Disagree 
71% (840) 
Q41. The J-shaped hormetic model shown in the figure indicates that at low doses risk of 
disease is reduced.  
Agree 
62% (772) 
Disagree 
38% (467) 
Q42. If hormesis is present, the traditional use of safety factors or uncertainty factors is not 
necessary. 
Generally Agree 
12% (152) 
Generally Disagree 
88% (1095) 
Q43. If hormesis were accepted as the default model for risk assessment, current and past 
risk assessment decisions should be formally re-evaluated. 
Generally Agree 
64% (786) 
Generally Disagree 
36% (448) 
Q44. Risk assessments based on the hormesis dose response could address chemical 
mixtures as effectively as linear and threshold based risk assessments. 
Generally Agree 
58% (663) 
Generally Disagree 
42% (487) 
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 4.3.1 Selection of Variables for Univariate and Multivariate Analysis 
The chi-square test was calculated for all variables and all questions as described 
in Chapter 3.  The test results were exported to an Excel spreadsheet.  This spreadsheet 
was visually scanned to identify variables that consistently demonstrated heterogeneity 
across multiple questions.  Sixteen variables were identified as variables of interest based 
on the chi-square screening analysis.   
The demographic variables found to be statistically significant across most 
questions were gender, highest attained degree, and society membership.  An a priori 
hypothesis that political, economic and social views would be predictive of those who 
would accept or reject hormesis was not supported by the data.  The variables 
representing years of experience, subject age, nationality, and when a subject completed 
the survey were not found to be potential indicators of acceptance or rejection of 
hormesis. 
Three broad employment categories were consistently significant: 1) employment 
by a government regulatory agency, 2) employment in the private sector (industry) and 3) 
employment in academia.  The category government regulatory agency contained the US 
Environmental Protection Agency (EPA) subset that was evaluated and consistently 
found to be predictive of a lower acceptance rate, but not a rejection of hormesis as will 
be explained later in this chapter.  Three US government agencies showed a strong 
acceptance of hormesis based on chi-square screening, Department of Energy, 
Department of Defense, and the Food and Drug Administration but were not were not 
carried forward as variables for detailed examination due to the low total number of 
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 subjects in each category (n<100).  Subjects who worked for State government agencies 
had a low acceptance rate for hormesis but were not carried forward, also due to low 
numbers (n< 100). The industry category contained two employment subsets that were 
significant and proved predictive of opinions toward hormesis; ever employed by the 
pharmaceutical industry and ever employed in environmental consulting.  The remaining 
variables representing industry classifications were not significant. Note that respondents 
could select multiple job categories.  Most respondents selected one job category 
(n=1,088).  The remaining subjects selected none (n=27), two categories (n=201) or three 
or more categories (n=147).   
The specialty variables found to be statistically significant and with a sufficient 
number of respondents (n>100) to carry forward in the analysis were general toxicology, 
developmental and reproductive toxicology, inhalation toxicology, neurotoxicology, 
regulatory policy, and risk assessment.  The veterinary and ecology specialties were 
consistently accepting of hormesis, but were not carried forward due to low numbers of 
respondents (n<100).  As with job categories, respondents were asked to select all 
specialty categories that applied.  Most subjects selected two categories (n=321), 
followed closely by those that selected one category (n=315).  Many respondents selected 
three (n=288) and four (n=230) specialty categories.   
Univariate odds ratios were calculated for each variable.  Variables found to be 
statistically significant were entered as covariates into the multivariate logistic regression 
analysis. 
 54
 4.3.2 Univariate and Multivariate Analysis of Policy Questions 
4.3.2.1 Univariate and Multivariate Analysis of Policy Question 32 About the 
Widespread Applicability of the Hormesis Dose-Response Model 
Question 32 specifically states “sufficient data exist to suggest hormesis occurs in 
a wide range of species and endpoints following low-dose exposure to a broad range of 
chemical agents and physical stressors.”  The overall result was that 48% of respondents 
agreed with the statement.  The sixteen variables of interest were examined and the 
results are shown in Table 4.9.  Only two variables, women (OR=0.75, 95% CI=0.58, 
0.96) and pharmaceutical industry employment (OR=0.59, 95% CI=0.42, 0.83) were 
found to be significantly associated with the view of the widespread applicability of the 
hormesis dose-response model, both in the direction of not subscribing to this view of 
hormesis. 
The two variables were entered as covariates in the logistic regression analysis 
shown in Table 4.10.  Both remained significantly associated after adjustment. Therefore, 
the null hypotheses of no difference between male and female respondents, and no 
difference between pharmaceutical workers and all other workers were rejected. Women 
and respondents who were ever employed by the pharmaceutical industry are more likely 
to disagree with question 32, that hormesis is common across species and endpoints.  
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 Table 4.9: Univariate analysis results for question 32 on the universality of the 
hormesis dose-response 
 
 
Agree Disagree Variable 
No.            %      No.                % 
Odds Ratio 95% CI1 P-Value 
Gender 
   Male 
   Female 
 
410 
158  
 
51 
43      
 
306  
206 
 
49 
57 
 
1.0 
0.75 
 
Reference 
0.58, 0.96 
 
- 
0.024 
Education 
   BS/MS 
   PhD, JD,MD,DVM 
 
114 
459 
 
48 
48 
 
124 
495 
 
52 
52 
 
1.0 
1.0 
 
Reference 
0.75,  1.35 
 
- 
1.0 
Society 
   SOT 
   SRA 
 
413  
162 
 
47 
50 
 
460 
162 
 
53 
50 
 
1.0 
1.14 
 
Reference 
0.86, 1.44  
 
- 
0.445 
Gov’t Reg. Agency 
   No 
   Yes 
 
467 
108 
 
49 
46 
 
494 
128 
 
51 
54 
 
1.0 
0.89 
 
Reference 
0.66, 1.20  
 
- 
.479 
EPA Only 
   No 
   Yes 
 
552 
23 
 
48 
41 
 
589 
33 
 
52 
59 
 
1.0 
0.75 
 
Reference 
0.41, 1.32 
 
- 
0.351 
Ever EPA 
   No 
   Yes 
 
532 
43 
 
47 
41 
 
561 
61 
 
52 
59 
 
1.0 
0.74 
 
Reference 
0.48, 1.14 
 
- 
0.184 
Ever Industry 
   No 
   Yes 
 
291 
284 
 
49 
47 
 
301 
321 
 
51 
53 
 
1.0 
0.91 
 
Reference 
0.72, 1.16 
 
- 
0.479 
Ever Pharmaceutical 
   No 
   Yes 
 
506 
69 
 
50 
37 
 
506 
116 
 
50 
63 
 
1.0 
0.59 
 
Reference 
0.42, 0.83 
 
- 
0.001 
Ever Envron. Consult 
   No 
   Yes 
 
507 
68 
 
47 
55 
 
566 
56 
 
53 
45 
 
1.0 
1.36 
 
Reference 
0.93, 2.01 
 
- 
0.132 
Academic 
   No 
   Yes 
 
398 
177 
 
47 
52 
 
456 
116 
 
53 
48 
 
1.0 
1.22 
 
Reference 
0.94, 1.58 
 
- 
0.133 
General Toxicology 
   No 
   Yes   
 
233 
342 
 
50 
47 
 
231 
391 
 
50 
53 
 
1.0 
0.87 
 
Reference 
0.68, 1.10 
 
- 
0.254 
Devel/Reproductive 
   No 
   Yes    
 
491 
84 
 
48 
49 
 
535 
87 
 
52 
51 
 
1.0 
1.05 
 
Reference 
0.75, 1.47 
 
- 
0.822 
Inhalation Toxicology 
   No 
   Yes 
 
508 
67 
 
48 
56 
 
543 
79 
 
34 
35 
 
1.0 
0.91 
 
Reference 
0.63,1.30 
 
- 
0.642 
Neurotoxicology 
   No 
   Yes 
 
508 
67 
 
48 
50 
 
554 
68 
 
52 
50 
 
1.0 
1.07 
 
Reference 
0.76, 1.56 
 
- 
0.762 
Regulatory Policy 
   No 
   Yes 
 
471 
104 
 
49 
44 
 
488 
134 
 
35 
37 
 
1.0 
0.80 
 
Reference 
0.59, 1.08 
 
- 
0.154 
Risk Assessment 
   No 
   Yes 
 
299 
276 
 
48 
48 
 
323 
299 
 
33 
37 
 
1.0 
1.0 
 
Reference 
0.78, 1.25 
 
- 
1.0 
Abbreviations: CI, Confidence Interval; Gov’t Reg. Agency, government regulatory 
agency; Envron, environmental; Devel, developmental 
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 Table 4.10: Multivariate logistic regression analysis results for question 32 on the 
widespread applicability of the hormesis dose-response model 
 
 
Agree Disagree Covariate 
No.          %      No.           %     
Univariate 
Odds Ratio 
Adjusted  
Odds Ratio 
95% CI1 
Adjusted 
OR 
Gender 
   Male 
   Female 
 
410 
158 
 
51 
43     
 
306 
206 
 
49 
57 
 
1.0 
0.75 
 
1.0 
0.72 
 
Reference 
0.56, 0.93 
Ever Pharmaceutical 
   No 
   Yes 
 
506 
69 
 
50 
37 
 
506 
116 
 
50 
63 
 
1.0 
0.59 
 
1.0 
0.58 
 
Reference 
0.42, 0.80 
Abbreviations: CI, confidence interval; OR, odds ratio 
 
 
4.3.2.2 Univariate and Multivariate Analysis of Policy Question 36 about Modifying 
Risk Assessment Procedures to Include Potential Benefit 
Question 36 specifically states “Risk assessment procedures should be modified 
to obtain potential benefits associated with hormesis.”   This question was designed to 
evaluate whether respondents would accept modifying risk assessment procedures to 
include potential benefit associated with hormesis.  The overall result for this question 
was 59% agreed procedures should be modified to include potential benefit.  Additional 
analysis was conducted to ascertain which respondents were most likely to agree.  The 
sixteen variable of interest were examined and the results are shown in Table 4.11. The 
odds ratios and 95% CI indicated the following eight variables could be predictive of 
acceptance or rejection: 1) highest degree attained; 2) employment by a government 
regulatory agency; 3) being employed only by EPA; 4) being ever employed by EPA; 5) 
employment in the private sector (industry); 6) employment as an environmental  
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 Table 4.11: Univariate analysis for question 36 about modifying risk assessment 
procedures to obtain benefit from hormesis  
 
95% CI1 P-Value Variable Agree Disagree Odds Ratio 
 No.            %     No.            %    
Gender        
   Male 490 59 341 41 1.0 Reference - 
   Female 213  59      150 41 0.99 0.76, 1.28 0.976 
Education        
   BS/MS 167 66 86 34 1.0 Reference - 
   PhD, JD,MD,DVM 543 57 417 43 0.67 0.49,  0.90 0.008 
Society        
   SOT 505 58 370 43 1.0 Reference - 
   SRA 209 61 134 39 1.14 0.88, 1.43  0.336 
Gov’t Reg. Agency        
   No 597 61 381 39 1.0 Reference - 
   Yes 117 49 123 51 0.61 0.45, 0.81 0.0007 
EPA Only 
   No 
 
695 
19 
 
60 
32 
 
 
Abbreviations: CI, Confidence Interval; Gov’t Reg. Agency, government regulatory 
agency; Envron, environmental; Devel, developmental 
 
   Yes 
464 
40 
 
40 
 
1.0 
0.32 
 
Reference 
0.17, 0.57 
 
- 
68 <0.0001 
Ever EPA  
60 
44 
 
442 
62 
 
   No 
   Yes 
 
666 
48 
40 
56 
 
1.0 
 
Reference 
0.34, 0.78 
 
- 
0.001 0.51 
Ever Industry 
   No 
   Yes 
 
341 
373 
 
56 
 
273 
231 
 
44 
38 
 
1.0 
1.29 
 
Reference 
1.03, 1.64 
 
- 
62 0.032 
Ever Pharmaceutical 
   No 
 
   Yes 
605 
109 
 
58 
 
430 
74 
 
42 
40 
 
1.0 
1.04 
 
Reference 
60 0.75, 1.46 
 
- 
0.844 
Ever Envron. Consult 
   No 
   Yes 
 
629 
85 
 
58 
67 
 
463 
 
42 
33 
 
1.0 
1.56 
  
Reference - 
41 1.02, 2.32 0.04 
Academic 
   No 
   Yes 
 
499 
215 
 
58 
60 
 
359 
145 
 
42 
40 
 
1.0 
 
Reference 
0.82, 1.38 
 
- 
0.659 1.07 
General Toxicology 
   No 
   Yes   
  
61 
57 
 
299 
418 
192 
312 
 
39 
 
1.0 
0.85 
 
Reference 
0.67, 1.29 
 
- 
43 0.20 
Devel/Reproductive 
   No 
   Yes    
 
627 
 
60 
51 
 
421 
83 
 
87 
40 
49 
 
1.0 
 
Reference 
0.50, 0.99 
 
- 
0.70 0.04 
Inhalation Toxicology 
   No 
 
636 
78 
 
59 
53 
 
   Yes 
435 
69 
 
41 
 
1.0 
0.78 
  
Reference - 
47 0.55, 1.12 0.171 
  Neurotoxicology      
Reference -    No 649 60 431 40 1.0 
0.59 0.41, 0.86 0.005    Yes 65 47 73 53 
Regulatory Policy 
   No 
   Yes 
 
568 
146 
 
58 
61 
 
409 
95 
 
42 
39 
 
1.0 
1.11 
 
Reference 
0.82, 1.49 
 
- 
0.154 
Risk Assessment 
   No 
   Yes 
 
367 
347 
 
58 
59 
 
264 
240 
 
42 
41 
 
1.0 
1.04 
 
Reference 
0.82, 1.31 
 
- 
0.780 
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 consultant; 7) specializing in developmental and reproductive toxicology; and 8) 
specializing in neurotoxicology.   
 The variables representing employment in government regulatory agency, 
EPA only, and Ever EPA were found to be highly correlated.  The variable “Gov’t Reg. 
Agency” was selected to carry forward in the multivariate logistic regression model 
because the 95% CI was smaller and the total number of respondents was larger.  The 
variables ever employed industry and ever employed environmental consultant also found 
to be statistically correlated. Ever employed industry was selected for the multivariate 
logistic regression model because it had the narrowest 95% CI and the largest number of 
respondents.  In addition to the sixteen variables of interest, political, social and 
economic views were identified by chi-square screening analysis to be statistically 
significant for question 36.  Univariate and multivariate analysis of political, social and 
economic views was conducted to determine whether the variables were correlated, and if 
so, select the variable that would be entered into the multivariate logistic regression 
model.  For this analysis the reference group was set as “conservative”.   Based on the 
results of the analysis the variable “political” had the most significant odds ratios (i.e., 
lowest significance level) after adjusting for the effects of the covariates social and 
economic; thus was selected for the overall multivariate analysis of question 36.  The 
univariate and multivariate analysis of the covariates (political, social, and economic) are 
summarized in Table 4.12.   
Six variables were entered into the multivariate analysis.  Four variables remained 
significant when adjusted for the effects of the other covariates.  The adjusted odds ratios 
resulting from the multivariate logistic regression analysis are shown in table 4.13. 
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 Table 4.12:  Univariate and multivariate analysis for political, social, and economic 
variables for question 36 about modifying risk assessment procedures to obtain 
benefit from hormesis 
 
Agree Disagree Adjusted 95% CI Variable 
No.          %     No.         %      
Odds 
Ratio 
95% CI 
Univariate Odds 
Ratio 
Adjusted 
Political  
   Conservative 
   Middle of the 
Road 
   Liberal 
   Choose no 
Response 
Social 
   Conservative 
   Middle of the 
Road 
   Liberal 
   Choose no 
Response 
 
108 
315 
243 
45 
 
 
94 
295 
280 
40 
 
67 
62 
53 
54 
 
 
61 
65 
54 
53 
 
54 
192 
215 
39 
 
 
59 
160 
243 
36 
 
33 
38 
47 
46 
 
 
39 
35 
46 
47 
 
1.0 
0.82 
0.56 
0.58 
 
 
    1.0 
1.15 
0.72 
0.70 
 
Reference 
0.56, 1.19 
0.39, 0.82 
0.34, 0.98 
 
 
Reference 
0.79, 1.69 
0.50, 1.04 
0.40, 1.21 
 
1.0 
0.66 
0.58 
0.70 
 
 
1.0 
0.66 
0.58 
0.70 
 
Reference 
0.39, 1.12 
0.32, 1.06 
0.27, 1.75 
 
 
Reference 
0.98, 2.76 
0.67, 1.95 
0.37, 3.76 
Economic 
   Conservative 
   Middle of the 
Road 
   Liberal 
   Choose no 
Response 
 
195 
349 
126 
37 
 
64 
59 
53 
51 
 
109 
245 
111 
36 
 
36 
41 
47 
49 
 
1.0 
0.79 
0.63 
0.57 
 
Reference 
0.60, 1.06 
0.49, 0.90 
0.34, 0.96 
 
1.0 
0.88 
0.87 
0.69 
 
Reference 
0.63, 1.24 
0.56, 1.36 
0.23, 2.12 
 
 60
 Table 4.13: Multivariate logistic regression analysis results for question 36 about 
modifying risk assessment procedures to include benefit from hormesis 
 
Agree Disagree Covariate 
No.          %   No.          %   
Univariate 
Odds Ratio 
Adjusted 
Odds Ratio 
95% CI 
Adjusted 
OR 
Education 
   BS/MS 
   PhD, MD, JD, DVM 
 
167 
543 
 
66 
57    
 
86 
417 
 
34 
43 
 
1.0 
0.67 
 
1.0 
0.68 
 
Reference 
0.51. 0.92 
Gov’t Reg. Agency 
   No 
   Yes 
 
597 
117 
 
61 
49 
 
381 
123 
 
39 
51 
 
1.0 
0.61 
 
1.0 
0.63 
 
Reference 
0.47, 0.85 
Ever Industry 
   No 
   Yes 
 
341 
373 
 
56 
62 
 
273 
231 
 
44 
38 
 
1.0 
1.29 
 
1.0 
1.09 
 
Reference 
0.86, 1.40 
Develop/Reproductive 
   No 
   Yes 
 
627 
87 
 
60 
51 
 
421 
83 
 
40 
49 
 
1.0 
0.70 
 
1.0 
0.80 
 
Reference 
0.57, 1.12 
Neurotoxicology 
   No 
   Yes   
 
649 
65 
 
60 
47 
 
431 
73 
 
40 
53 
 
1.0 
0.59 
 
1.0 
0.67 
 
Reference 
0.46, 0.97 
Political  
   Conservative 
   Middle of the Road 
   Liberal 
   Choose no Response 
 
108 
315 
243 
45 
 
67 
62 
53 
54 
 
54 
192 
215 
39 
 
33 
38 
47 
46 
 
1.0 
0.82 
0.56 
0.58 
 
1.0 
0.83 
0.58 
0.55 
 
Reference 
0.57, 1.21 
0.40, 0.85 
0.32, 0.96 
Abbreviations: Gov’t Reg Agency, Government Regulatory Agency; OR, odds ratio 
 
Respondents with the highest attained degree of PhD were in overall agreement 
with modifying risk assessment to accommodate hormesis (57%) but were significantly 
less likely to agree than respondents with bachelor and masters degrees (66%).  
Respondents ever employed by a government regulatory agency were less likely 
to accept a change to accommodate hormesis (49% agree). Employment by industry was 
not a significant indicator when adjusted for the effects of the other covariates.   
The specialty of developmental and reproductive toxicology was not a significant 
predictor in the model.  However, the specialty of neurotoxicology remained significant  
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 and subjects with this specialty were less likely to agree with changing risk assessment 
procedures to evaluate potential benefit (47% agree).  
Compared to political conservatives; respondents who had liberal views or chose 
not to respond, were less likely to agree that risk assessment procedures should be 
modified to obtain potential benefits associated with hormesis.   
Question 36 was selected for detailed comment analysis because it was thought 
that this question might elicit a “passionate” response about the respondent’s opinion of 
hormesis.  The question received 323 comments.  Only questions, 16, 24, and 30 received 
more comments.  The comments were scored, positive, negative and neutral/explanation 
of response.  One comment was scored as positive, 23 responses were negative, 
remaining responses were scored as neutral because the respondent was simply 
explaining his/her choice for agreeing or disagreeing or providing suggestions for 
improving clarity and meaning of the question.  Negative comments tended to focus on 
two themes; perceived dangers in including an analysis of benefit and creation of an 
“industry loophole.”  Neutral comments were directed to the need for conclusive data 
supporting benefit.  If the respondent agreed with question 36, the comment indicated 
more data were needed.  If the respondent disagreed, the comment was a caveat that 
agreement depended on sufficient conclusive data.  The implications of the comments are 
explored further in Chapter 5: Discussion.    
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 4.3.2.3 Univariate and Multivariate Analysis of Policy Question 38 about Re-
Evaluating Regulations if Hormesis Were the Default Model 
The question specifically states “If hormesis were accepted as the default model 
for risk assessment, current regulations should be re-evaluated.” Many of the current 
government regulations are based on default dose-response models; linear-non threshold 
for carcinogenic compounds and threshold for all other potential toxicants.  This question 
requests the respondent to consider a situation in which the regulatory default was the 
hormesis dose-response and asks whether regulations should be re-evaluated.  The overall 
result for this question was that 77% of respondents agreed regulations should be re-
evaluated.   
Four variables met the criteria for statistical significance: 1) highest attained 
degree 2) ever employed by a government regulatory agency 3) employed only by EPA 
and 4) ever employed by EPA.  The variables representing employment in government 
regulatory agency, EPA only, and Ever EPA were found to be highly correlated.  The 
variable “Gov’t Reg. Agency” was selected to carry forward in the multivariate logistic 
regression model because the 95% CI was narrower in the univariate analysis and the 
total number of respondents was larger.  Results of the univariate analysis on the 
variables of interest are presented in Table 4.14.   
Highest attained degree and ever employed by a government regulatory agency, 
were entered as covariates in a logistic regression analysis. The two covariates remained 
significant when adjusted for the effects of one another.  Although 76% of respondents 
with PhD’s agreed that current regulations should be re-evaluated if hormesis were 
accepted as the default risk assessment model, they were significantly less likely to agree  
 63
  
Table 4.14: Univariate analysis results for question 38 about re-evaluating 
regulations if hormesis were the default model 
 
Agree Disagree Variable 
No.             %    No.           %     
Odds Ratio 95% CI P-Value 
Gender 
   Male 
   Female 
 
636 
283  
 
77 
79      
 
193 
73 
 
23 
21 
 
1.0 
1.18 
 
Reference 
0.86, 1.62 
 
- 
0.33 
Education 
   BS/MS 
   PhD, JD,MD,DVM 
 
204 
724 
 
83 
76 
 
42 
230 
 
17 
24 
 
1.0 
0.65 
 
Reference 
0.44,  0.94 
 
- 
0.021 
Society 
   SOT 
   SRA 
 
668 
265 
 
76 
80 
 
207 
65 
 
24 
20 
 
1.0 
1.26 
 
Reference 
0.92, 1.76  
 
- 
0.163 
Gov’t Reg. Agency 
   No 
   Yes 
 
769 
164 
 
79 
69 
 
200 
72 
 
21 
31 
 
1.0 
0.59 
 
Reference 
0.43, 0.83  
 
- 
0.002 
EPA Only 
   No 
   Yes 
 
901 
35 
 
78 
58 
 
249 
23 
 
22 
42 
 
1.0 
0.42 
 
Reference 
0.24, 0.76 
 
- 
0.004 
Ever EPA 
   No 
   Yes 
 
867 
66 
 
79 
63 
 
234 
38 
 
21 
37 
 
1.0 
0.47 
 
Reference 
0.30, 0.74 
 
- 
0.001 
Ever Industry 
   No 
   Yes 
 
458 
475 
 
76 
78 
 
141 
131 
 
24 
22 
 
1.0 
1.12 
 
Reference 
0.84, 1.48 
 
- 
0.466 
Ever Pharmaceutical 
   No 
   Yes 
 
799 
134 
 
78 
73 
 
223 
49 
 
22 
27 
 
1.0 
0.76 
 
Reference 
0.53, 1.12 
 
- 
0.170 
Ever Envron. Consult 
   No 
   Yes 
 
826 
107 
 
77 
84 
 
252 
20 
 
23 
16 
 
1.0 
1.63 
 
Reference 
0.98, 2.84 
 
- 
0.06 
Academic 
   No 
   Yes 
 
660 
268 
 
77 
78 
 
197 
75 
 
23 
22 
 
1.0 
1.07 
 
Reference 
0.78, 1.46 
 
- 
0.735 
General Toxicology 
   No 
   Yes   
 
384 
549 
 
80 
76 
 
95 
177 
 
20 
24 
 
1.0 
0.77 
 
Reference 
0.57, 1.02 
 
- 
0.07 
Devel/Reproductive 
   No 
   Yes    
 
805 
128 
 
78 
74 
 
228 
44 
 
22 
26 
 
1.0 
0.82 
 
Reference 
0.56, 1.23 
 
- 
0.356 
Inhalation Toxicology 
   No 
   Yes 
 
826 
107 
 
78 
71 
 
229 
43 
 
22 
29 
 
1.0 
0.69 
 
Reference 
0.46, 1.04 
 
- 
0.075 
Neurotoxicology 
   No 
   Yes 
 
832 
102 
 
78 
76 
 
240 
32 
 
22 
24 
 
1.0 
0.91 
 
Reference 
0.59, 1.44 
 
- 
0.73 
Regulatory Policy 
   No 
   Yes 
 
753 
180 
 
77 
78 
 
220 
52 
 
23 
22 
 
1.0 
1.01 
 
Reference 
0.72, 1.45 
 
- 
1.0 
Risk Assessment 
   No 
   Yes 
 
483 
450 
 
77 
78 
 
143 
129 
 
23 
22 
 
1.0 
1.03 
 
Reference 
0.78, 1.37 
 
- 
0.87 
Abbreviations: CI, Confidence Interval; Gov’t Reg. Agency, government regulatory 
agency; Envron, environmental; Devel, developmental 
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 than respondents with bachelor and masters degrees. The result for was similar for 
respondents ever employed by a government regulatory agency (69 vs.79%).  The 
adjusted odds ratios are presented in Table 4.15.  
 
Table 4.15:  Multivariate logistic regression results for question 38 about re-
evaluating regulations if hormesis were the default model 
 
Agree Disagree Covariate 
No.          %     No.          %     
Univariate 
Odds Ratio 
Adjusted 
 Odds Ratio 
95% CI 
Adjusted OR 
Education 
   BS/MS 
   PhD, JD, MD, 
DVM 
 
204 
724 
 
83 
76     
 
42 
230 
 
17 
24 
 
1.0 
0.65 
 
1.0 
0.64 
 
Reference 
0.44, 0.92 
Gov’t Reg. Agency 
   No 
   Yes 
 
769 
164 
 
79 
69 
 
200 
72 
 
21 
31 
 
1.0 
0.59 
 
1.0 
0.59 
 
Reference 
0.43, 0.81 
Abbreviations: Gov’t Reg. Agency, government regulatory agency; OR, odds ratio 
 
4.3.2.4 Univariate and Multivariate Analysis of Policy Question 39 about Modifying 
Hazard Assessment to Accommodate the Phenomenon of Hormesis 
The question specifically states “The phenomenon of hormesis justifies a change 
in hazard assessment protocols (e.g. sample size, number of doses, timing of doses).”   
The overall result was that 65% of respondents agreed with the statement.  This is 
an important indicator as to whether researchers would accept changing hazard 
assessment design including sample size, timing and number of doses in order to reliably 
detect a hormetic dose-response.   
Eight variables met the criteria for statistical significance: 1) being a woman;  2) 
employment by a government regulatory agency; 3) employment only by EPA; 4) 
employment in the pharmaceutical industry; 5) employment as an environmental  
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Table 4.16: Univariate analysis results for question 39 about modifying hazard 
assessment to accommodate hormesis  
 
Agree Disagree Variable 
No.             %     No.             % 
Odds Ratio 95% CI P-Value 
Gender 
   Male 
   Female 
 
518 
255 
 
63 
72      
 
306 
101 
 
37 
28 
 
1.0 
1.49 
 
Reference 
1.13, 1.98 
 
- 
0.004 
Education 
   BS/MS 
   PhD, JD,MD,DVM 
 
175 
603 
 
70 
64 
 
76 
342 
 
30 
36 
 
1.0 
0.76 
 
Reference 
0.56,  1.04 
 
- 
0.093 
Society 
   SOT 
   SRA 
 
562 
219 
 
64 
67 
 
312 
108 
 
36 
33 
 
1.0 
1.13 
 
Reference 
0.85, 1.49  
 
- 
0.427 
Gov’t Reg. Agency 
   No 
   Yes 
 
650 
131 
 
67 
57 
 
320 
100 
 
33 
43 
 
1.0 
0.65 
 
Reference 
0.48, 0.87  
 
- 
.004 
EPA Only 
   No 
   Yes 
 
755 
26 
 
60 
48 
 
392 
28 
 
34 
52 
 
1.0 
0.48 
 
Reference 
0.27, 0.87 
 
- 
0.01 
Ever EPA 
   No 
   Yes 
 
722 
59 
 
66 
58 
 
377 
43 
 
34 
42 
 
1.0 
0.72 
 
Reference 
0.47, 1.11 
 
- 
0.141 
Ever Industry 
   No 
   Yes 
 
395 
386 
 
66 
64 
 
200 
220 
 
34 
36 
 
1.0 
0.89 
 
Reference 
0.70, 1.13 
 
- 
0.359 
Ever Pharmaceutical 
   No 
   Yes 
 
686 
95 
 
67 
52 
 
332 
88 
 
33 
48 
 
1.0 
0.52 
 
Reference 
0.38, 0.73 
 
- 
<0.0001 
Ever Envron. Consult 
   No 
   Yes 
 
682 
99 
 
63 
79 
 
394 
26 
 
37 
21 
 
1.0 
2.20 
 
Reference 
1.39, 3.59 
 
- 
0.0004 
Academic 
   No 
   Yes 
 
537 
244 
 
63 
71 
 
318 
102 
 
37 
29 
 
1.0 
1.42 
 
Reference 
1.07, 1.87 
 
- 
0.013 
General Toxicology 
   No 
   Yes   
 
327 
454 
 
69 
62 
 
145 
275 
 
31 
38 
 
1.0 
0.73 
 
Reference 
0.57, 0.94 
 
- 
0.015 
Devel/Reproductive 
   No 
   Yes    
 
667 
114 
 
65 
67 
 
363 
57 
 
35 
33 
 
1.0 
1.01 
 
Reference 
0.76, 1.56 
 
- 
0.69 
Inhalation Toxicology 
   No 
   Yes 
 
699 
82 
 
66 
55 
 
354 
66 
 
34 
35 
 
1.0 
0.63 
 
Reference 
0.44, 0.91 
 
- 
0.012 
Neurotoxicology 
   No 
   Yes 
 
691 
90 
 
65 
67 
 
375 
45 
 
35 
33 
 
1.0 
1.08 
 
Reference 
0.73, 1.62 
 
- 
0.748 
Regulatory Policy 
   No 
   Yes 
 
633 
148 
 
65 
63 
 
334 
86 
 
35 
37 
 
1.0 
0.91 
 
Reference 
0.67, 1.24 
 
- 
0.573 
Risk Assessment 
   No 
   Yes 
 
413 
368 
 
67 
63 
 
205 
215 
 
33 
37 
 
1.0 
0.85 
 
Reference 
0.66, 1.08  
 
- 
0.198 
Abbreviations: CI, Confidence Interval; Gov’t Reg. Agency, government regulatory 
agency; Envron, environmental; Devel, developmental 
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 consultant; 6) employment in academia; 7) specializing in  general toxicology; and 8) 
specializing inhalation toxicology. Odds ratios and 95% confidence intervals for all 
variables are presented in Table 4.16.  
Because half the variables were statistically significant and potential indicators of 
who accept modifying hazard assessment to accommodate hormesis, the variables were 
tested for correlation using step-wise logistic regression analysis.  The variable ever 
employed by a government regulatory agency was selected for the multivariate logistic 
regression over the EPA subsets because the confidence interval was narrower and the 
total number of respondents was larger.  Correlation testing indicated the remaining 
variables were not correlated and all were entered into the multivariate analysis.   
Seven variables were entered into the multivariate logistic regression model.  Five 
variables remained significant after adjusting for the effects of covariates. Women were 
more likely than men to agree with changing hazard assessment protocols (72 vs.63%).  
Respondents that were ever employed as environmental consultants were more likely to 
agree when compared to all other employment categories (79 vs. 63%).  Respondents 
ever employed by a government regulatory agency (57%) or ever employed by a 
pharmaceutical company (52%) were less likely to agree with changing hazard 
assessment protocols as compared to all other employment categories.  Respondents with 
the specialty of inhalation toxicology were less likely to agree to changes in hazard 
assessment protocols than all other specialties (55%). The variables “ever employed in an 
academic setting” and “specialty general toxicology” were no longer significant when 
adjusted for the effects of the other covariates.  The adjusted odds ratios are provided in 
Table 4.17. 
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 Table 4.17: Multivariate analysis results for question 39 about modifying hazard 
assessment to accommodate hormesis  
 
Agree Disagree Covariate 
No.          %     No.          %     
Univariate 
Odds Ratio 
Adjusted 
Odds Ratio 
95% CI 
Adjusted OR 
Gender 
   Male 
   Female 
 
518 
255 
 
63 
72     
 
306 
101 
 
37 
28 
 
1.0 
1.49 
 
1.0 
1.44 
 
Reference 
1.09, 1.90 
Gov’t Reg. Agency 
   No 
   Yes 
 
650 
131 
 
67 
57 
 
320 
100 
 
33 
43 
 
1.0 
0.65 
 
1.0 
0.61 
 
Reference 
0.44, 0.83 
Ever Pharmaceutical 
   No 
   Yes 
 
686 
95 
 
67 
52 
 
332 
88 
 
33 
48 
 
1.0 
0.52 
 
1.0 
0.58 
 
Reference 
0.41, 0.82 
Ever Envron. Consult 
   No 
   Yes 
 
682 
99 
 
63 
79 
 
394 
26 
 
37 
21 
 
1.0 
2.20 
 
1.0 
2.11 
 
Reference 
1.32, 3.37 
Inhalation 
Toxicology 
   No 
   Yes 
 
699 
82 
 
66 
55 
 
354 
66 
 
34 
35 
 
1.0 
0.63 
 
1.0 
0.64 
 
Reference 
0.45, 0.92 
Abbreviations: CI, Confidence Interval; Gov’t Reg. Agency, government regulatory 
agency; Envron, environmental; OR, odds ratio 
 
4.3.2.5 Evaluation of Question 26 about Respondents’ Actual Observations of 
Hormetic Dose-Response on Response to the Four Policy Questions 
Question 26 asks respondents about their dose-response research observations.  
The purpose of evaluating this question was to determine whether first-hand observation 
of a hormetic dose-response effect, affects respondents attitudes toward hormesis.   Of 
the approximately 1,100 respondents with direct research experience observing biological 
responses, approximately half (n=555) reported direct experience observing a hormetic 
dose-response either commonly or occasionally.  The results are provided in Table 4.18. 
The 555 respondents who commonly or occasionally observed biological 
responses that best fit the hormesis dose response were evaluated to determine whether 
their opinions on the policy questions differed from their colleagues who rarely or never 
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 Table 4.18: Data on respondents who reported observing biological responses that 
best fit the threshold, linear non-threshold, and hormetic dose-response models 
 
Q26: In my 
research 
biological 
responses that 
best fit the 
following model 
are:  
Common 
No.                  % 
Occasional 
No.               % 
Rare 
No.              % 
Never  
No.              % 
Hormesis 
LNT 
Threshold 
127                  12 
237                  22 
759                  68 
428                   39 
392                   36 
260                   23 
366               34 
309               28 
63                   6 
171               16 
153               14 
39                   3 
     Abbreviations: LNT, linear non-threshold 
 
observed hormesis.  This group with direct experience observing a hormetic dose-
response had a tendency to agree with the policy questions that favor hormesis, whereas 
those who had rare to no personal research experience observing a hormetic dose-
response were less likely to favor hormesis, except for question 38 on hormesis as the 
default model.  The results are provided in Table 4.19. 
 
Table 4.19: Results for respondents who observed hormesis commonly, occasionally, 
rarely or never vis-a-vis the four policy questions 
 
In my research hormesis 
dose response 
is observed: 
Q321 
General 
% Agree 
Q362 
Benefit 
% Agree 
Q383 
Default 
% Agree 
Q394 
Dosing 
% Agree 
Commonly 
Occasionally 
79 
58 
75 
65 
82 
81 
81 
73 
Rarely 
Never 
31 
31 
50 
42 
74 
65 
54 
57 
 
1. Q32 Sufficient data exist to suggest hormesis occurs in a wide range of species and endpoints following 
low-dose exposure to a broad range of chemical agents and physical stressors.                                                                             
2. Q36 Risk assessment procedures should be modified to obtain potential benefits associated with 
hormesis.                                                                                                                                                                                   
3. Q38 If hormesis were accepted as the default model for risk assessment, current regulations should be re-
evaluated.                                                                                                                                                                                         
4. Q39 The phenomenon of hormesis justifies a change in hazard assessment protocols (e.g. sample size, 
number of doses, timing of doses). 
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 4.4 Internal Consistency Analysis 
Two tests for internal consistency were built into the questionnaire.  Chronbach’s 
coefficient alpha was used as the statistical measure of internal reliability.  This statistic 
tests whether the survey elicits consistent and reliable responses between questions 
designed to ask related questions that have similar responses.  The Alpha coefficient 
ranges between 0 and 1, with higher scores indicating greater internal consistency.  
For this survey, if a person disagreed with question 15 “Regulatory upper-bound 
characterizations used in cancer risk assessments provide accurate estimates of the 
probability of developing cancer” they were thought to be likely to answer agree to 
question 19 “the linear model employed in cancer risk assessment overstates risk in the 
low dose zone” because both questions evaluate the respondents opinion on the current 
dose-response default model for cancer risk assessment.   The result was 0.24, indicating 
a moderately low consistency in responses.   
The second test was between questions 31 and 41.  Question 31 states “if a study 
reliably shows a J-shaped dose response curve, it implies low dose effects could be 
beneficial.” Question 41 makes essentially the same statement “the J-shaped hormetic 
model shown in the figure indicates that at low doses risk of disease is reduced.”  The 
Chronbach’s alpha coefficient for this comparison was 0.51.  
4.5 Evaluation of Response Bias 
 The purpose of this section is to address concerns that those who responded to the 
survey differed from those who did not.  The first step of the evaluation was conducted 
by analyzing responses between those who completed the survey and those who did not.  
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 Then auxiliary information provided by the SOT on membership characteristics was used 
to compare with SOT study respondents to identify whether large differences existed 
between society membership as a whole and study respondents.  Additional information 
was provided by researchers conducting a similar survey shortly after the current survey, 
which was used to further examine potential for response bias.  Finally, coded comments 
were evaluated. 
 
4.5.1 Comparisons of Subjects who Completed the Questionnaire to Subjects who 
Did Not  
In order to address concerns about response bias the characteristics of those who 
completed the survey were compared to those who started the survey, but dropped out 
along the way.  The null hypothesis tested was that there was no difference between those 
who started and those who completed.   
The sixteen variables evaluated for the four policy questions were also evaluated 
for this analysis.  The only variables that were statistically significant were 1) being a 
member of the Society for Risk Analysis and 2) selecting “choose not to respond” as an 
answer to the social, economic, and political views questions.   These results are 
discussed further in Chapter 5. Analytical results for the sixteen variables of interest plus 
social, economic, and political views are shown in Tables 4.20 and 4.21.      
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 Table 4.20: Univariate analysis of sixteen variables tested for policy questions 
comparing respondents who completed the questionnaire (answered Q43) to 
respondents who dropped out in Sections 3, 4, or 5 
 
Dropped  Completed Variable 
No.             %     No.            % 
Odds Ratio 95% CI1 P-Value 
Gender 
   Male 
   Female 
 
167 
93  
 
17 
21      
 
816  
354 
 
83 
79 
 
1.0 
1.3 
 
Reference 
0.96, 1.79 
 
- 
0.08 
Education 
   BS/MS 
   PhD, JD,MD,DVM 
 
68 
201 
 
22 
18 
 
242 
945 
 
78 
82 
 
1.0 
0.75 
 
Reference 
0.56,  1.03 
 
- 
0.07 
Society 
   SOT 
   SRA 
 
175  
96 
 
17 
23 
 
870 
322 
 
83 
77 
 
1.0 
1.48 
 
Reference 
1.12, 1.96  
 
- 
0.005 
Gov’t Reg. Agency 
   No 
   Yes 
 
210 
61 
 
18 
21 
 
956 
227 
 
82 
79 
 
1.0 
1.23 
 
Reference 
0.90, 1.70  
 
- 
.19 
EPA Only 
   No 
   Yes 
 
254 
17 
 
18 
24 
 
1139 
53 
 
82 
76 
 
1.0 
1.44 
 
Reference 
0.82, 2.53 
 
- 
0.20 
Ever EPA 
   No 
   Yes 
 
245 
26 
 
18 
20 
 
1089 
103 
 
82 
80 
 
1.0 
1.12 
 
Reference 
0.71, 1.76 
 
- 
0.62 
Ever Industry 
   No 
   Yes 
 
142 
129 
 
19 
18 
 
589 
603 
 
81 
82 
 
1.0 
1.29 
 
Reference 
0.91, 1.81 
 
- 
0.10 
Ever Pharmaceutical 
   No 
   Yes 
 
220 
51 
 
18 
22 
 
1010 
182 
 
82 
78 
 
1.0 
1.29 
 
Reference 
0.91, 1.81 
 
- 
0.37 
Ever Envron. Consult 
   No 
   Yes 
 
251 
20 
 
19 
14 
 
1065 
127 
 
81 
86 
 
1.0 
0.67 
 
Reference 
0.41, 1.10 
 
- 
0.11 
Academic 
   No 
   Yes 
 
199 
72 
 
19 
18 
 
855 
337 
 
81 
82 
 
1.0 
0.92 
 
Reference 
0.68, 1.23 
 
- 
0.57 
General Toxicology 
   No 
   Yes   
 
115 
156 
 
19 
18 
 
478 
714 
 
81 
82 
 
1.0 
0.91 
 
Reference 
0.69, 1.19 
 
- 
0.48 
Devel/Reproductive 
   No 
   Yes    
 
239 
32 
 
19 
16 
 
1019 
173 
 
81 
84 
 
1.0 
0.79 
 
Reference 
0.53, 1.18 
 
- 
0.24 
Inhalation Toxicology 
   No 
   Yes 
 
242 
29 
 
19 
17 
 
1048 
144 
 
81 
83 
 
1.0 
0.87 
 
Reference 
0.57,1.33 
 
- 
0.52 
Neurotoxicology 
   No 
   Yes 
 
242 
29 
 
19 
18 
 
1057 
135 
 
81 
82 
 
1.0 
0.94 
 
Reference 
0.61, 1.43 
 
- 
0.23 
Regulatory Policy 
   No 
   Yes 
 
214 
57 
 
18 
19 
 
955 
237 
 
82 
81 
 
1.0 
0.96 
 
Reference 
0.74, 1.25 
 
- 
0.67 
Risk Assessment 
   No 
   Yes 
 
143 
128 
 
19 
18 
 
616 
576 
 
81 
82 
 
1.0 
0.96 
 
Reference 
0.74, 1.25 
 
- 
0.75 
Abbreviations: CI, Confidence Interval; Gov’t Reg. Agency, government regulatory 
agency; Envron, environmental; Devel, developmental
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 Table 4.21: Univariate analysis of political, social, and economic variables 
comparing respondents who completed the questionnaire (answered Q43) to 
respondents who dropped out in Sections 3, 4, or 5 
 
Dropped  Completed Variable 
No.           %       No.             % 
Odds Ratio 95% CI 
Political  
   Conservative 
   Middle of the Road 
   Liberal 
   Choose no Response 
Social 
   Conservative 
   Middle of the Road 
   Liberal 
   Choose no Response 
 
26 
93 
115 
35 
 
24 
95 
114 
34 
 
14 
16 
21 
30 
 
14 
17 
18 
33 
 
163 
502 
439 
80 
 
149 
452 
512 
69 
 
86 
84 
79 
70 
 
86 
83 
82 
67 
 
1.0 
0.86 
0.61 
0.37 
 
1.0 
0.76 
0.72 
0.33 
 
Reference 
0.54, 1.37 
0.38, 0.97 
0.21, 0.65 
 
Reference 
0.47, 1.24 
0.45, 1.16 
0.18, 0.59 
Economic 
   Conservative 
   Middle of the Road 
   Liberal 
   Choose no Response 
 
50 
135 
50 
32 
 
14 
19 
18 
33 
 
305 
585 
228 
64 
 
86 
81 
82 
67 
 
1.0 
0.71 
0.75 
0.33 
 
Reference 
0.50, 1.01 
0.48, 1.47 
0.19, 0.55 
 
 
4.5.2 SOT Demographic Comparison 
 External validity is achieved in part by in assessing whether respondents’ 
characteristics reflect the characteristics of the society membership as a whole.  The 
Society of Toxicology provided general demographic information on its membership that 
was used to compare to those who responded to the survey.  The bar graphs in Figures 
4.6, 4.7, and 4.8 indicate the SOT study respondents closely match the society 
membership. 
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Figure 4.6: Bar chart showing gender and years of experience similarities between 
the SOT membership and SOT study respondents 
 
 
 
 
Figure 4.7: Bar chart showing educational similarities between the SOT 
membership and SOT study respondents 
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Figure 4.8: Bar chart showing employment similarities between SOT membership 
and SOT study respondents 
 
4.5.3 Comparisons with Survey Information from a Similar Study of SOT 
Less than three months after the Hormesis Knowledge and Opinions survey was 
administered to the Society of Toxicology membership, George Mason University in 
conjunction with the Society of Toxicology administered a census survey to those who 
were listed as full members of SOT to ascertain their opinions about specific chemical 
risks.  The researchers distributed an online questionnaire toall 3,562 full members of the 
SOT. The survey was open from January 27 through March 2, 2009.   They had a return 
rate of 32%.  Over 200 people dropped the survey after completing the demographic 
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 section for an adjusted response rate of 26%.   Their overall findings were based on 
responses of the 937 who continued after the demographic section.  The George Mason 
researchers kindly provided their demographic data to this investigator for comparison.  
Unlike the George Mason survey, the Hormesis survey was distributed to all SOT 
members, including students.  In order to make similar comparisons, the student members 
and members with < 5 years of experience (representing associate members) were 
dropped from the hormesis survey.  Overall the two surveys are remarkably similar on 
most criteria as shown in Figures 4.9, 4.10, 4.11.  Comparisons for gender, age and 
regional demographics are virtually identical (Figures 4.9, 4.10).  The areas of 
employment do not match exactly but are similar. The lack of an exact match may be 
because the hormesis survey respondent was able to check all the employment types and 
specialties that applied, whereas the George Mason/SOT survey respondents were 
restricted to selecting one category that best described the respondent. 
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Figure 4.9: Comparison of the George Mason survey demographic data with the 
Hormesis Survey demographics 
 
 
 
 
Figure 4.10 Comparison of the George Mason survey regional representation with 
the Hormesis Survey respondents  
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Figure 4.11: Comparison of the George Mason survey employment areas with the 
Hormesis Survey respondents 
 
4.5.4 Evaluation of Responses 
The research committee suggested coding comments to Questions 36, 45 and 46 
as to whether they were negative, neutral, or positive toward hormesis in an effort to 
indirectly evaluate response bias.  The results are summarized in Figure 4.12.  For the 
purposes of this study, if comments were overwhelmingly positive or negative, over 20% 
in either direction, it was concluded response bias could be present. If however, the 
overwhelming majority of comments, 80%, were neutral then it was concluded response 
bias may be low.  For question 36 only 7% of responses were coded as negative.  This is 
a significant result because this question, above all others was predicted to elicit a 
negative response.  A discussion of some of the more interesting responses is included in 
Chapter 5.  Question 45 was a request for comments about content that may have been 
missed, 81% of comments were coded neutral, 11% were negative, and 8% were positive.  
Eleven of the 38 negative comments indicated the respondent thought the survey was 
biased to favor hormesis.  Question 46 was a request for information about what could 
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Figure 4.12: Positive, neutral and negative comments of questions 36, 45 and 
46 indicating that most comments were neutral, meaning they were informative 
rather than critical 
 
 
have been done to make the survey better.  81% were coded neutral, 12% were negative, 
and 7% were positive.  Nine of the 39 negative comments indicated the respondent 
thought the survey was biased toward hormesis.  For both questions 45 and 46, 
approximately 10% of the neutral comments were suggestions to use Likert-type rating 
scale rather than the dichotomous scale employed in the survey.  
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 CHAPTER 5 
DISCUSSION 
5.1 Introduction 
The goals of this first-ever survey of the acceptance and understanding of the 
hormesis dose-response concept among toxicologists and risk assessors were to ascertain 
attitudes on hormesis and other dose-response models; and to identify  how the level of 
acceptance or rejection of hormesis is related to knowledge of or experience with 
hormesis, predisposing values, or demographic characteristics.  This chapter begins with 
a discussion of the major findings related to the research goals, followed by a discussion 
of study limitations.   
5.2  Major Findings 
A primary rationale for this study was to determine whether toxicologists and risk 
assessors believe that hormesis commonly occurs across biological systems, endpoints, 
and chemical classes as has been reported in reviews of the literature (Anderson, 2005; 
Calabrese and Baldwin 2001a,d; Calabrese and Blain, 2005; Cook and Calabrese, 2006 
a); or whether the survey respondents believe that hormesis dose-response is a rare event 
(Mushak, 2007; Thayer et al., 2005). Contrary to expectation, 50% of the respondents 
indicated they believe sufficient data presently exist to support the view that hormesis 
occurs across a wide range of species and endpoints.  The fact that half of the respondents 
accept the broad generalizability of hormesis is  notable because, aside from the 
published literature, hormesis is ignored or rejected outright by regulatory agencies 
(USEAP, 2004). The survey further indicates that most respondents have not taken 
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 advantage of the few training opportunities available for hormesis; 90% of respondents 
indicated they never attended a hormesis workshop and 93% indicated they had never 
attended a conference on hormesis.   Furthermore, 75% had never received any classroom 
instruction on the topic.  
The finding is even more striking when one considers not just small number of 
respondents attending learning opportunities, but also the relative lack until recently of 
published studies reporting a hormesis dose-response.  It is possible that the proliferation 
of recent publications may have had an impact on respondent opinions on the 
generalizability of hormesis.  A search of the Web of Science ® database shows that 
citations of the keywords hormesis or hormetic  occurred at approximately 15 per year 
throughout the decade of the 1980’s, then in the 1990’s the citation rate slowly increased, 
ending the decade with a total of 200 citations for the year 1999.  Citations increased 
rapidly in the current decade and finally doubled from 1,100 citations in 2006 to over 
2,200 in 2008.    
Interestingly, characteristics of the respondents such as: years of experience, the 
society of membership, level of education, place of residence, most types of employment 
(excluding government and pharmaceutical companies), and political, economic or social 
views did not have a direct influence on their opinion on the broad generalizability of 
hormesis.  
One of the largest influences on willingness to take hormesis into consideration as 
a valid biological model of dose-response was experience with hormesis based on actual 
research.  Seventy-nine percent of subjects who reported observing the hormesis dose-
response commonly in their studies agreed with the statement that hormesis is broadly 
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 generalizable across multiple species and biological endpoints.  Indeed, commonly or 
occasionally observing hormesis in one’s own research had a profoundly positive impact 
on respondent’s opinions on all of the policy questions. 
Only two groups of respondents were found to be statistically significantly less 
supportive of the statement that hormesis occurs widely across species and endpoints: 
women (43% agreed) and those employed by the pharmaceutical industry (37% agreed).  
The variables were tested for correlation and were found to be independent and not 
correlated with any other variable, including social and political leanings.  The open-
ended comments made by women (n=42) indicated they did not reject the concept of 
hormesis per se, but thought sufficient data do not exist to support broad generalizability 
at this time.   
The finding that only 37% of those employed by pharmaceutical companies 
agreed that hormesis occurred across the broad biological spectrum was unexpected.   
Indeed, prior to the study, it was hypothesized that this group would be much more likely 
to subscribe to the view that hormesis is common across multiple species and endpoints.  
This a priori assumption was made because much of the dose-response data in the 
published literature are derived from studies of pharmaceutical agents (Calabrese and 
Blain, 2005).  Additionally, two issues of the journal Critical Reviews in Toxicology 
(McClellan, 2001, 2008) dedicated to hormesis present the results of a large number of 
pharmaceutical research studies demonstrating the hormesis dose-response.  Because the 
finding was unexpected the comments were evaluated.  Among the open-ended 
comments of those who disagreed (n=18), most stated that although hormesis is 
frequently detected in pharmaceutical research, the studies are not sufficient to support 
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 the view that hormesis occurs in all species and biological responses across multiple 
agents and stressors.   
Ironically, strong support for including an evaluation of public health benefit was 
shown by those employed by the pharmaceutical industry (60%).  This high level of 
support is an interesting juxtaposition to the group’s seeming rejection of the statement 
that hormesis is broadly generalizable.  However, this may be explained when one 
considers the objective of drug discovery is to evaluate multiple doses in a more or less 
linear fashion of promising formulations in order to identify the beneficial zone for 
therapeutic impact, while at the same time establishing drug safety by identifying adverse 
reactions, which are typically dose-related.  Simply put, drug discovery is to promote 
successful treatment while minimizing harm. The fact that benefit or harm may occur at 
low doses is clearly important to this group. 
Despite the fact that EPA (2004) has explicitly excluded from risk assessment the 
analysis of public health benefit associated with low-dose exposure, 59% of respondents 
indicated that the potential for hormesis benefit should be included in a risk assessment.  
These findings suggest that toxicologists and risk assessors are willing to consider 
biological realities rather than conventional mathematic models such as the linear or 
threshold.   
Support for including an analysis of benefit was found across most of the 
surveyed population.  The only group that strongly disagreed (68%) with evaluating 
potential for public health benefit was EPA employees.  This suggests that EPA policy 
may have biased their views, or that the institutional structure in place has reduced the 
range of acceptable thought within the agency.     
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 Strong desire on the part of a majority of respondents (59%) to modify risk 
assessment in order to evaluate potential benefits at low doses may indicate that 
respondents would welcome the opportunity to analyze multiple dose response curves 
instead of forcing the data to fit default models that may or may not represent the 
biological reality.   Groups strongly supportive of the ability to consider benefit (60% or 
greater agree) were academics, those employed by industry, members of the Society for 
Risk Analysis, political and social conservatives and moderates , environmental and 
toxicological consultants, pharmacologists and regulatory policy specialists.  
The only group other than government regulatory agencies, specifically EPA, in 
disagreement with changing risk assessment procedures to examine potential public 
health benefit from hormesis was the group identifying with a specialty of 
neurotoxicology.  47% of respondents in this group agreed with modifying risk 
assessment to identify benefits. This finding appears to be unusual given the general 
finding that the hormesis dose-response not only dominates the field of neuroscience 
research but is the basis for many therapeutic agents for neurodegenerative diseases.  
Many of the therapeutic agents for these diseases rely on a beneficial low-dose 
stimulatory response (Diamond, 2008; Kastin and Pan, 2008; Mattson, 2008).   An 
explanation may be found in the fact that neuroscience studies rarely report findings as 
hormesis; instead the researchers rely on a variety of dose-response descriptions 
including U-shaped, bell curve, biphasic, bitonic, and others (Calabrese, 2008).  
Researchers could simply be unaware of the concept of hormesis as it relates to their 
study results.  Alternatively, respondents may be employing a cautious self-revisionist 
epistemic approach to hormesis as suggested by some neuroscience experts (Giordano et 
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 al., 2008).  The open ended comments provided by neurotoxicologists who disagree with 
including an analysis of benefit in risk assessment (n= 32) indicate that the explanations 
proposed by both Calabrese (2008) and Giordano et al. (2008) may be true.   Most 
indicated biological systems were too variable and therefore incorporation of benefit was 
not warranted, others indicated they selected to disagree because not enough data existed, 
while a few indicated they did not completely understand the utility of hormesis for 
determining benefit or harm.   
In fact, the rest of the open ended comments about the concept of incorporating 
hormesis into risk assessment followed the tenor of responses from the 
neurotoxicologists.  None of the comments espoused passionate or extremely negative 
opinions about hormesis as expected.  The vast majority (93%) of those providing 
comments about the concept of benefit were explaining their answers and they too tended 
to focus on population variation, the desire for more data, or the desire to know more 
about hormesis before agreeing.  The few negative responses focused on perceived 
dangers of assuming benefit and concern about the creation of an “industry loophole.” 
However, none of the comments was passionately for or against the concept which 
indicates that most toxicologists and risk assessors are seeking a rational, data-driven 
approach to risk assessment that incorporates all available data and is sensitive to 
biological complexity. 
The finding of support for evaluating benefit is validated by the finding that a 
majority of all respondents (65%) are in favor of modifying hazard assessment protocols 
to identify the presence of hormesis.  This opinion was held across all sectors, regardless 
of demographic characteristic, years of experience, employment history, politic, social, or 
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 economic views, or any other characteristic.  Even those employed by government 
regulatory agencies and neurotoxicologists who were against applying hormesis to obtain 
a public health benefit were in favor of designing studies that could identify the presence 
of the hormesis phenomenon.  In particular, neurotoxicologists are strongly (67%) in 
favor of modifying study designs to identify whether the hormesis dose-response is 
present.  
Because all groups agreed (93%) on the definition of hormesis that states the 
dose-response exhibits biological responses at low doses that are opposite to those 
observed at high doses and because all groups agree hormesis could be either beneficial 
or harmful (71%) it is consistent that such a large majority (65%) would be supportive of 
modifying dose-response studies (sample size, number and timing of doses) to determine 
whether hormesis was present.  In addition, support for modifying dose-response 
assessments to identify hormesis has been expressed by a variety of researchers 
representing diverse areas of specialty.  The scientists state that research efforts should be 
redirected from looking only at adverse effects at high doses and adjusted to be able to 
identify whether adverse or beneficial biological effects are occurring at heretofore 
unstudied lower doses (Kastin and Pan, 2008; Stumpf, 2006; Thong and Maibach, 2007). 
Indeed, the support for modifying dose-response study designs suggest that respondents 
are interested in conducting thorough dose-response assessments capable of clearly 
delineating the true shape of the dose response.   
The final major result is that 75% of respondents indicated current regulations 
should be re-evaluated if hormesis were accepted as the default model for risk 
assessment.  Not surprisingly, subjects who were ever employed by a government 
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 regulatory agency were somewhat less likely to agree (69%) but, 69% is still a large 
majority of the group.  Although this was a hypothetical question, using the word “if” as 
a request for the respondent to speculate, a very specific conclusion can be drawn from 
the response: toxicologists and risk assessors appear to be willing to reexamine their 
research methods, and study designs, as well as the risk assessment paradigm.    They 
may be in agreement with Giordano et al., (2008) who point out that as knowledge grows, 
empirical evidence must direct what is studied, how it is studied, and how the results are 
interpreted in the future. 
Overall the survey results provide an important snap-shot of toxicologists’ and 
risk assessors’ knowledge about the science of risk assessment and hormesis, and their 
opinions on the policies used by regulatory agencies to interpret the science.  The 
hormesis dose-response appears to be gaining acceptance as a legitimate biological 
phenomenon worthy of attention.  The detailed chi-square and logistic regression 
analyses revealed that no single demographic or personal characteristic among the over 
50 studied was routinely or dramatically associated with the respondents acceptance or 
rejection of hormesis as a biological concept in risk assessment.  A majority of the 
scientists who took this survey appear to be guided by science and not predisposing 
beliefs. 
The fact that 1,247 subjects took on average 30 minutes of their time to complete 
the entire 44 question technical survey and in many cases provide detailed and thoughtful 
comments supports the idea that interest in hormesis is growing, as is a re-examination of 
the underlying assumptions of risk assessment model in general.  The field of risk 
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 assessment may truly be at a point where scientists are willing and eager to explore 
models that reflect the true biology of dose-response.   
5.3 Limitations 
An opinion survey of this type is not without its limitations.  High survey 
response rates help ensure survey results are representative of the target population. The 
anticipated response rate for this email-based internet survey was 25% based on the 
literature for email delivered surveys (Hamilton, 2003; Kaplowitz et al., 2004).  The 
return rate, meaning those who clicked on the email invitation and opened the survey, 
was 23% for the Society of Toxicology (SOT), close to what was expected.  However the 
SOT adjusted response rate after removing those who completed the demographics 
section and did not continue was 18% representing 1,045 individuals, lower than hoped.  
The Society for Risk Analysis (SRA) return and response rates were much lower at 16% 
and 12% respectively.  This was expected because of a limitation in the sampling frame 
which consisted of a large fraction of risk management professionals such as aviation and 
infrastructure professionals who have no knowledge of chemical or radiation risks.  For 
some survey research studies, a low response rate such as the one experienced by this 
study may be considered problematic and give rise for concern about non-response bias.  
However, for this particular survey, the concerns for non-response bias may not be 
warranted because those respondents were representative of the societies from which they 
were derived.  SOT respondents were used to evaluate external validity because the SRA 
did not supply comparative data and because of the sampling frame issues mentioned 
earlier.  The demographic characteristics of the SOT respondents are nearly identical to 
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 the demographic characteristics of the society as a whole.  The comparative data are 
considered highly reliable because they were supplied by SOT and were derived from 
membership applications.  In addition, the characteristics and responses of the present 
hormesis survey respondents are nearly identical to SOT members who responded to a 
survey on Risk Communication administered by George Mason University researchers 
three months after the hormesis survey closed.  The George Mason survey had an 
adjusted response rate of 26% (n=937 SOT full members).  The respondents to the two 
surveys who were full members of SOT were closely matched with respect to gender, 
years of experience and average age.  Comparisons by country and region of residence in 
the United States are identical.  The only differences between the two surveys were in the 
area of employment.  The hormesis survey had 9% fewer academics, but 11% more 
respondents employed by the government.  
The internal measures also suggest bias may be low.  No substantial differences 
exist between those who started the survey and those who finished.  The only notable 
difference was that members of SRA dropped out of the survey at a slightly higher rate 
than SOT members.  This may be expected due to the sampling frame issues previously 
described.  Over twenty SRA members took the time to send an email to the link 
provided on the invitation, to indicate that they were not familiar with chemical risk 
assessment or the concept of hormesis and therefore declined to take the survey.  No SOT 
members sent emails indicating they were not familiar with the topic. 
The final limitation is one found in all surveys, the concern that respondents 
understand the meaning and intention of the question.  A few of the open ended 
comments indicated that in some instances respondents did not understand what was 
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 being asked by a particular question or meant by a specific term.  However, these 
comments were made mostly on the definition questions, for which some of the 
respondents did not know whether the survey was asking for the regulatory definition or 
their opinion.  The definition questions did not impact the analysis of overall opinion.  
Finally, many respondents indicated the survey would have been better if it had provided 
the respondent with a Likert scale instead of the dichotomous responses.  Admittedly, the 
respondent was not informed in the Introduction or in the body of the surrey that the 
instrument was designed to elicit responses that were not neutral or that would require 
reclassification to accommodate statistical analysis.   
None of these limitations are likely to adversely affect in a serious manner the 
conclusions of this study.  It is likely that these results are in fact generalizable to the 
broader population of toxicologists and risk assessment professionals.  The phenomenon 
of hormesis appears to be recognized as a biological fact that should be seriously 
considered when designing, conducting and interpreting future risk assessments.    
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 CHAPTER 6 
CONCLUSIONS 
The goals of this study were to: 1) ascertain attitudes about hormesis and other 
dose-response models; 2) identify whether the level of acceptance or rejection of 
hormesis is based on knowledge of hormesis, existing social and political values, or 
demographic characteristics; 3) evaluate potential for response bias; and 4) establish 
research priorities for hormesis.   
An examination of the study participants’ answers to the survey questions 
indicates that a majority of toxicologists and risk assessors are knowledgeable about the 
hormesis dose-response and in fact accept it as a phenomenon worthy of scientific 
exploration and consideration.  Further, respondents demonstrated through their 
responses a strong desire to advance the science of risk assessment by taking into 
consideration dose-response models and research results that more accurately reflect the 
complexity of various biologic systems rather than employing an a priori default model 
that results in predictable, linear, non-threshold outcomes.   
Level of acceptance or rejection of hormesis among the scientists who 
participated in this first- ever survey on the topic of hormesis was not explained by any of 
the characteristics or predisposing values examined in this study, with the exception of 
employment in government regulatory agencies or pharmaceutical companies.  It was 
speculated a priori that many non-scientific aspects of a participant’s background 
including gender, education, work experience, membership in professional societies, 
socio-economic and political views, employment history, and toxicological specialty, 
may materially affect his/her opinion of hormesis and its utility in risk assessment.  
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 Therefore, data were collected on over 50 variables defining the above characteristics and 
none was predictive of a profile of who would generally be open to either accept or reject 
hormesis as a dose-response phenomenon.  It was found unexpectedly that only 
employment by a government regulatory agency was consistently predictive of a 
respondent being less accepting of hormesis. Prior to the survey, this researcher 
speculated that socio-economic and political views and gender would be consistently 
associated with respondent attitudes about hormesis and risk assessment. Specifically, it 
was thought that respondents with more liberal views and women would be less 
accepting of hormesis as a dose-response model for risk assessment because the concept 
is not entirely consistent with the now widely accepted precautionary principle, which 
asserts that conservative protective measures must be taken when cause-and-effect 
relationships have not been established, but only suggested by inconclusive studies.  
However, the data show that most respondents appear to be willing to follow the 
scientific evidence of discovery and investigation with regard to dose-response research 
and not be influenced by existing political or social views or belief systems.   
The survey clearly showed that those ever employed by government regulatory 
agencies and those employed by pharmaceutical companies do not accept hormesis as a 
widely generalizable phenomenon or a useful dose-response model.  Furthermore, 
respondents employed by government regulatory agencies had consistently more negative 
opinions toward hormesis as a dose-response model.  It has been speculated that for 
government workers this difference may be due to bias based on agency policy or agency 
culture.  It could also be due to self-selection by those more likely to agree with the 
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 default dose-response model and the precautionary principle, who select for employment 
in the regulatory environment. 
The influence of non-response bias was evaluated through several internal and 
external measures while keeping to the study promise of maintaining respondent 
anonymity.  Despite the lower than hoped for response rate, but because of the relatively 
robust external validity measures for Society of Toxicology members, it is concluded that 
respondents’ opinions are likely a reasonable representation of the societies of which they 
are members.  
Certainly a better understanding of hormesis and the desire to conduct studies that 
elucidate the full range of biological responses will likely lead to adoption of different 
strategies for evaluating dose-response as it applies to risk assessment, toxicology and 
pharmacology.  The survey results indicate that scientists are prepared to direct research 
away from the a priori default models for evaluating adverse health effects at high doses 
and begin to characterize and reflect the complex biological effects, both adverse and 
beneficial, that may occur at low-levels of exposure.  If this new approach or paradigm of 
dose-response research takes root and grows, a follow-up survey of the present study 
population may be in order.   
Any future survey design should separately evaluate the knowledge and science 
of dose-response from the regulatory approach to dose-response investigations in order to 
avoid conflating science with public policy, which is often not scientifically based. 
In conclusion, in order to truly understand how attitudes toward dose-response 
evolve over time, a prospective cohort study could be initiated in cooperation with the 
Society of Toxicology that administers a survey instrument similar to the one used in this 
 93
 study to student members of the Society with periodic follow-up to evaluate change in 
attitudes and opinion according to the various characteristics examined in the present 
investigation.  Such a study would be valuable for understanding the level of acceptance 
of the hormesis dose-response paradigm and for documenting changes in attitudes about 
and the conduct of risk assessment, and what factors affect these changes in attitudes.    
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 APPENDIX A 
 
SOCIETY OF TOXICOLOGY DEMOGRAPHIC INFORMATION  
REQUEST LETTER  
Amy C. Jones 
Environmental Health Sciences, Morrill I, N344 
University of Massachusetts 
Amherst, Massachusetts 01003 
 
 
April 7, 2009 
 
Dr. Kenneth S. Ramos 
President, Society of Toxicology 
1821 Michael Faraday Drive, Suite 300 
Reston, Virginia  20190 
 
Dear Dr. Ramos: 
 
I am a Full Member of the Society of Toxicology and member of the Society’s Carcinogenesis; 
Ethical, Legal and Social Issues; Occupational and Public Health; and Risk Assessment Specialty 
Sections.  I am also a doctoral student at the University of Massachusetts doing work on 
biological responses at low dose.  In particular, I am interested in the hormesis dose-response 
phenomenon.  Last September, I surveyed Society of Toxicology and Society for Risk Analysis 
members about their knowledge and opinions on the hormesis dose response model. The 
responses to the survey comprise the basis of my PhD thesis. 
 
The goals of the survey were to 1) ascertain respondents’ attitudes about various dose response 
models, including hormesis; 2) determine the characteristics of people who would, if allowed by 
the regulatory framework, take the potential for hormesis into account when designing and/or 
interpreting risk assessments; and 3) identify whether the level of acceptance or rejection of 
hormesis is based on scientific/educational training of the subject; predisposing social and 
political values; or demographic characteristics. 
 
I would like to evaluate the potential for response bias in my survey by comparing the 
demographic characteristics of respondents who completed the survey with the overall 
demographic characteristics of SOT membership. Without the overall SOT membership 
distribution data, it will be impossible for me to assess response bias in a valid manner; and any 
inference I draw on my survey’s results thus would be severely limited.  
 
SOT requests its members to voluntarily provide the following information that would be very 
helpful to my research: 
• Gender 
• Highest Degree 
• Years of Experience 
• Employment: Academia, Contract Research Organization, Government, Industry, 
Military, Not Employed, Other, Research Institute, and Student 
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 • Areas of Interest: General Toxicology, Reproductive and Developmental, Drug 
Discovery, Biotechnology, Carcinogenesis, Food Safety, Biological Modeling, etc.  
 
I am requesting the Society provide me a summary of the above referenced demographic data.  I 
do not require personally identifiable information, just the overall frequency distribution data for 
each demographic category. I will then compare the distribution of the above characteristics with 
the characteristics of my respondents in order to assess response bias. 
I thank you in advance for your kind attention to this request.   
 
If you would like to speak to me directly, please do not hesitate to call me at 301-758-0547.  My 
email address is amyn@schoolph.umass.edu. 
 
Sincerely, 
 
Amy Jones 
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SURVEY E-MAIL INVITATION 
 
 
Dear Colleague, 
 
I am a graduate student at the University of Massachusetts at Amherst, completing a 
Ph.D. thesis on the hormesis dose-response. I invite you to participate in my research by 
completing this survey to assess knowledge and opinions about dose response in general, 
and hormesis in particular.  
 
This survey is completely anonymous. Your responses will not be identified with you 
personally.  Responses will be assessed in aggregate only.   
 
The link to the survey is: 
http://www.surveymonkey.com/s.aspx?sm=n8uQQTBqX2wZ_2fweuyMfGAw_3d_3d 
 
The Institutional Review Board (IRB) at the University of Massachusetts Amherst has 
approved this study.  If you have concerns about this study you may contact me directly 
by email at amyn@schoolph.umass.edu  or by phone at 301-758-0547. Alternatively, you 
may contact the University’s Human Research Protection Office via email at 
humansubjects@ora.umass.edu or by phone at 413-545-3428. 
 
Final Survey results will be posted on the UMASS Environmental Health Sciences 
website at the completion of the study. 
 
You may withdraw from the survey at any time and may choose not to answer all 
questions. 
 
I appreciate your taking the time to complete this survey. 
 
Sincerely, 
Amy C. Jones 
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 APPENDIX C 
DOCUMENTATION OF SURVEY INSTRUMENT FINAL TEXT 
 
No. Question Purpose 
  
 Section 2 
The purpose of this section is to obtain 
information on age, sex, level of 
education, employment history, and/or 
geographical region  
1 
If you have taken this survey 
previously, please skip to the end. 
Potential respondents could have reveived 
more than one link depending on society 
membership. 
2 Residence Obtain important demographic information 
3 Age Obtain important demographic information 
4 Sex Obtain important demographic information 
5 Degrees Obtain important demographic information 
6 Employers Obtain important demographic information 
7 Specialties Obtain important demographic information 
8 Yrs Exp Obtain important demographic information 
9 Memberships Obtain important demographic information 
10 Info Sources Obtain important demographic information 
11 Social Obtain important demographic information 
12 Economic Obtain important demographic information 
13 Political Obtain important demographic information 
  
 
 
 
Section 3 
The purpose of this section is to assess 
your general knowledge about dose-
response assessment and various dose 
response models. 
14 
Dose-response assessment is a 
necessary foundation for 
understanding risk assessment. 
Dose-response is the foundation for 
toxicology.  Do the respondents think is is 
also the foundation for risk assessment? 
15 
Regulatory upper-bound 
characterizations used in cancer risk 
assessments provide accurate 
estimates of the probability of 
developing cancer at low doses. 
Risk assessments performed pursuant to 
certain regulatory frameworks require 
specific models to be applied to the data.  
Do the respondents agree with an example 
of a default model? 
16 
Exposure to a genotoxic carcinogen, 
no matter how small, theoretically 
results in an increased cancer risk. 
Regulatory framework question.  Do the 
respondents agree with the current 
regulatory framework for assessing 
genotoxic compounds? 
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17 
Exposure to non-genotoxic 
carcinogen, no matter how small, 
theoretically results in an increased 
cancer risk. 
Regulatory framework question.  Do the 
respondents agree with the current 
regulatory framework for assessing non-
genotoxic compounds? 
18 
Exposure to ionizing radiation (e.g. 
X-Rays), no matter how small, 
theoretically results in increased 
cancer risk. 
Regulatory framework question.  Do the 
respondents agree with the current 
regulatory framework for assessing ionizing 
radiation? 
19 
The linear model employed in 
cancer risk assessment overstates 
risk in the low dose zone. 
Regulatory framework question. How do the 
respondents interpret output from the LNT 
model? 
20 
The threshold dose-response 
assumes no treatment related 
responses occur below the 
estimated threshold. 
Knowledge question. Do respondents agree 
to the text book definition of a threshold 
dose-response? 
21 
The linear non-threshold (LNT) 
dose-response assumes a biological 
response is directly proportional to 
dose in the low dose zone. 
Knowledge question. Do respondents agree 
to the textbook definition of linear non-
threshold (LNT) dose-response. 
22 
The hormesis dose-response 
exhibits biological responses at low 
doses that are opposite to those 
observed at higher doses, leading to 
either a J-shaped or inverted U 
shaped dose-response curve. 
Knowledge question. Do the respondents 
agree to the definition of the hormesis dose-
response commonly published in the 
literature? 
23 
For effects other than 
carcinogenisis, most toxicants act in 
a manner consistent with the 
following model: 
Regulatory framework question.  Which of 
the two regulatory dose-response models 
plus hormesis do the respondents prefer for 
evaluating most toxicants? 
24 
Carcinogens typically act via the 
following dose-response model: 
Regulatory framework question.  Which of 
the two regulatory dose-response models 
plus hormesis do the respondents prefer for 
evaluating most toxicants? 
25 
Have you ever conducted 
experimental research in dose-
response? 
How many people who answered the 
survey have actually conducted dose 
response research? 
26 
In my research… Of the people who evaluate dose-response 
studies, how many have observed the 
various dose-responses listed? 
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 Section 4 
The purpose of this section is to assess 
your level of familiarity with hormesis. 
27 
Have you ever attended a seminar, 
workshop, or classroom 
presentation on the topic of 
hormesis? 
Personal instruction and scholarly discourse 
on hormesis is increasingly available.  How 
many respondents have experience with 
these sources of information?   
28 
How commonly do you think 
hormesis is observed in, 
A research goal is to identify research gaps.  
This question is intended to find out how 
commonly respondents think hormesis 
occurs in various types of studies. 
29 
If you answered uncommon, rare, 
artifactual, or do not know, to the 
preceding question, is it because 
you believe one of the following? 
This follow-on question asking why the 
respondent answered in a particular way is 
important.  Responses to this question will 
help identify whether the survey has strong 
response bias. If high number of does not 
apply, response bias favorable to hormesis 
may be present. 
30 
Any reproducible biological 
response to a toxic chemical or 
radiation exposure qualifies as an 
"adverse effect".  
A key component of the hormetic dose 
response is that biological effects at low 
doses could be either beneficial or 
detrimental depending on the shape of the 
curve and biologic endpoint.  How many 
respondents believe all measurable effects 
are adverse? 
31 
If a study reliably shows a J-Shaped 
dose response curve, it implies low 
dose effects could be beneficial 
How do respondents interpret the J-shaped 
hormesis dose-response? 
32 
Sufficient data exist to suggest 
hormesis occurs in a wide range of 
species and endpoints following 
low-dose exposure to a broad range 
of chemical agents and physical 
stressors. 
How many respondents agree with data on 
the occurrence of hormesis recently 
published review articles by Calabrese and 
others? 
33 
If study reproducibly demonstrates 
the hormesis dose-response, the 
implication for low doses would be: 
Do respondents understand the nature of 
the J and inverted U shaped curves?  
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 Section 5 
The purpose of this section is to obtain 
your opinion on risk assessment 
principles and assess how you interpret 
dose response models in conducting 
risk assessments. 
34 
What is your perspective on current 
state of chemical regulation? 
Regulatory policy question. What do 
respondents think of the current state of 
chemical regulation? 
35 
What is your perspective on current 
state of ionizing radiation 
regulations? 
Regulatory policy question. What do 
respondents think of the current state of 
ionizing radiation regulations? 
36 Risk assessment procedures should 
be modified to obtain potential 
benefits associated with hormesis. 
Regulatory policy question.  Would 
respondents be willing to modify risk 
assessment procedures if the hormetic 
dose response showed a protective 
response at low doses?   
37 
If a chemical exhibits a hormesis 
dose-response, the risk assessment 
should accommodate data. 
Regulatory policy question.  Would 
respondents be willing to follow the dose-
response data instead of applying a default 
model prescribed in a regulatory 
framework? 
38 
If hormesis were accepted as the 
default model for risk assessment, 
current regulations should be re-
evaluated. 
Regulatory policy question.  Would 
respondents be willing to change the 
regulatory decisions based on hormesis? 
39 
The phenomenon of hormesis 
justifies a change in hazard assess 
protocols (e.g. sample size, number 
of doses, timing of doses). 
Regulatory policy question. Scholarly 
articles have been published noting that 
hormesis cannot be reliably detected using 
the standard high dose study design.  Do 
respondents believe that hormesis is 
common enough to change the hazard 
identification model? 
40 
Acceptance of hormesis decreases 
the margin of safety in risk 
assessments. 
Regulatory policy question.  Do 
respondents belief that acceptance of 
hormesis would decrease the margin of 
safety in a risk assessment?   
41 
Hormetic model indicates that at low 
doses risk of disease is significantly 
reduced. 
Regulatory policy question.  How do the 
respondents interpret the J-shaped dose-
response depicted in the figure provided? 
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42 
If hormesis is present, the traditional 
use of safety factors not necessary. 
Regulatory policy question. The regulatory 
framework requires uncertainty factors to be 
incorporated into derivation of the final "safe 
dose".  Would adoption of hormesis change 
respondents attitudes toward safety 
factors? 
43 
If hormesis were accepted as the 
default model for risk assessment, 
current and past environmental risk 
assessment decisions should be 
formally re-evaluated? 
Regulatory policy question. Would 
respondents be open to changing risk 
assessment decisions if the regulatory 
framework was changed to account for 
hormesis? 
44 
Risk assessments based on the 
hormesis dose-response could 
address chemical mixtures as 
effectively as linear and threshold 
based risk assessments. 
Regulatory policy question. Chemicals 
mixtures are not regulated.  Do respondents 
think risk assessments based on the 
hormesis dose response could be effective 
at assessing chemical mixtures? 
  
 Section 6 
Thank-you, please take another few 
minutes to provide feedback on the 
survey, then press the submit button. 
45 
Do you have any suggestions about 
content we may have missed? Standard question for surveys. 
46 
What could we have done to make 
this survey better? Standard question for surveys. 
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